McGill.CA / Faculty of Dental Medicine and Oral Health Sciences / Research and Graduate Students / Our Researchers

Eduardo Franco

eduardo.franco [at] mcgill.ca (Email)

Professor
Department of Oncology
Faculty of Dentistry
Gerald Bronfman Centre
546 Pine Avenue West
Room 112
Montreal, Quebec, H2W 1S6
Tel. 514-398-6032

Research interests

Professor Franco's research during the last 28 years has focussed on the following topics: molecular epidemiology and prevention of cervical cancer and human papillomavirus-associated diseases, cancers of the upper aero-digestive tract, prostate, endometrium, and childhood tumours; studies of epidemiologic methods for evaluating efficacy of cancer screening strategies; the impact of measurement error in epidemiology; and studies of societal and clinical influences on cancer patient survival. Much of his research has been international, with collaborative projects in Canada, Brazil, the Congo Republic, United States, and with the International Agency for Research on Cancer, in France.

View complete profile

PUBLICATIONS (Peer-reviewed articles)

(*) corresponding author, (§) denotes a student of mine as first author

  1. Franco EL(*), Souza AVR. Experimental S. mansoni infection in mice: Blood white cells, serum proteins, glycemia, and blood urea in various stages of the infection. Revista do Instituto de Medicina Tropical de Sao Paulo, 21: 161-165, 1979.
  2. Franco EL(*), Duarte EF, Souza AVR, Corsini AC. A quantitative method for determining Toxoplasma gondii, white cells, and the volume of ascitic fluid in experimentally infected mice. Journal of Parasitology 66: 852-853, 1980.
  3. Franco EL(*), Sulzer AJ, Higby RW, Peralta JM. Immunoglobulin G and immunoglobulin M polar staining of Toxoplasma gondii in the indirect immunofluorescence test. Journal of Clinical Microbiology 12: 780-784, 1980.
  4. Franco EL(*), Walls KW, Sulzer AJ. Reverse enzyme immunoassay for detection of specific anti-Toxoplasma immunoglobulin M antibodies. Journal of Clinical Microbiology 13: 859-864, 1981.
  5. Walls KW(*), Franco EL. Reversed enzyme immunoassay. Lyon Medical 248 (suppl.): 43-49, 1982.
  6. Franco EL(*), Sulzer AJ. Indirect immunofluorescence test for antimalarial antibodies: influence of temperature, time of incubation, and presence of cell monolayers on the antigenic characteristics of Plasmodium falciparum matured “in vitro”. Revista do Instituto de Medicina Tropical de Sao Paulo 25: 229-235, 1983.
  7. Franco EL(*), Walls KW, Sulzer AJ, Soto JC. Diagnosis of acute acquired toxoplasmosis with the enzyme-labelled antigen reversed immunoassay for immunoglobulin M antibodies. Journal of Immunoassay 4: 373-393, 1983.
  8. Bradley LA, Franco EL, Reisner HM(*). Use of monoclonal antibodies in an enzyme immunoassay for factor VIII-related antigen. Clinical Chemistry 30: 87-92, 1984.
  9. Franco EL(*), Walls KW, Sulzer AJ, Campbell GH, Roberts JM. Computer-assisted multiple categorization of absorbance values in ELISA through pictorial emulation of 96-well plates. Journal of Immunological Methods 70: 45-52, 1984.
  10. Campbell GH(*), Miller LH, Hudson D, Franco EL, Andrysiak PM. Monoclonal antibody characterization of Plasmodium falciparum antigens. American Journal of Tropical Medicine and Hygiene 33: 1051-1054, 1984.
  11. Franco EL. Immunoserology of Malaria. Revista do Instituto de Medicina Tropical de Sao Paulo 28: 111-125, 1986.
  12. Sulzer AJ(*), Franco EL, Takafuji E, Benenson M, Walls KW, Greenup RL. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year. American Journal of Tropical Medicine and Hygiene 35: 290-296, 1986.
  13. Guimaraes MCS(*), Celeste BJ, Franco EL. Evaluation of Dot enzyme-linked immunosorbent assay for mucocutaneous leishmaniasis and comparison with microplate enzyme-immunoassay. Journal of Clinical Microbiology 24: 364-367, 1986.
  14. Franco EL(*), Simons AR. Simple algorithms for the representation of deterministic and stochastic versions of the Reed-Frost epidemic model using a programmable calculator. American Journal of Epidemiology 123: 905-915, 1986.
  15. Possik RA(§), Franco EL(*), Pires DR, Wohnrath DR, Ferreira EB. Sensitivity, specificity, and predictive value of laparoscopy for the staging of gastric cancer and for the detection of liver metastases. Cancer 58: 1-6, 1986.
  16. Pacheco MM, Oshima CT, Lopes MP, Widman A, Franco EL(*), Brentani MM. Steroid hormone receptors in male breast diseases. AntiCancer Research 6: 1013-1018, 1986.
  17. Brentani MM, Franco EL(*), Oshima CT, Pacheco MM. Androgen, estrogen, and progesterone receptor levels in malignant and benign breast tumors: A multivariate analysis approach. International Journal of Cancer 38: 637-642, 1986.
  18. Franco EL. A monoclonal antibody-based enzyme immunoassay to detect specificities in malarial antisera: A preliminary report. Memorias do Instituto Oswaldo Cruz 81: 229-230, 1986.
  19. Camargo B(§), Andrea ML, Franco EL(*). Catching up with history: Treatment of Wilms’ tumor in a developing country. Medical and Pediatric Oncology 15: 270-276, 1987.
  20. Franco EL. Epidemiology of cancers of the upper respiratory and digestive system. Revista Brasileira Cirurgia de Cabeca e Pescoco 11: 23-33, 1987.
  21. Franco EL(*), Campos-Filho N, Villa LL, Torloni H. Correlation patterns of cancer relative frequencies with some socioeconomic and demographic indicators in Brazil: An ecologic study. International Journal of Cancer 41: 24-29, 1988.
  22. Andrea ML, Camargo B, Alves AC, Franco EL(*). Factors of prognostic importance in childhood non-Hodgkin's lymphoma treated with two modified LSA2-L2 protocols: A multivariate analysis approach. Cancer 62: 240-250, 1988.
  23. Pacheco MM, Brentani MM, Franco EL(*), Fontelles JA, Chamone DF, Marques LA. Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study. International Journal of Cancer 41: 798-804, 1988.
  24. Campos-Filho N, Franco EL(*). Microcomputer-assisted univariate survival data analysis using Kaplan-Meier life table estimators. Computer Methods and Programs in Biomedicine 27: 223-228, 1988.
  25. Campos-Filho N, Franco EL(*). A microcomputer program for multiple logistic regression by unconditional and conditional maximum likelihood methods. American Journal of Epidemiology 129: 439-444, 1989.
  26. Villa LL, Franco EL(*). Epidemiologic correlates of cervical neoplasia and risk of human papillomavirus infection in asymptomatic women in Brazil. Journal of the National Cancer Institute 81: 332-340, 1989.
  27. Zacharias DPM, Franco EL(*), Monteiro J, Maciel MS, Regazzini R, Calvis LA, Abranches ID, Belfort FA, Bandiera DC. Chemotherapy of disseminated melanoma with bleomycin, vincristine, CCNU, and DTIC (BOLD regimen). Cancer 63: 1676-1680, 1989.
  28. Franco EL(*), Kowalski LP, Oliveira BV, Curado MP, Pereira RN, Silva ME, Fava AS, Torloni H. Risk factors for oral cancer in Brazil: A case-control study. International Journal of Cancer 43: 992-1000, 1989.
  29. Erwenne CM(§), Franco EL(*). Age and lateness of referral as determinants of extra-ocular retinoblastoma. Ophthalmic Paediatrics and Genetics 10: 179-184, 1989.
  30. Del Giglio A(§), Franco EL(*), Torloni H, Marques LA, Brentani MM, Arap W, Macchione M, Chammas R. Tumor and serum beta-2 microglobulin expression in women with breast cancer. American Journal of Clinical Pathology 92: 339-342, 1989.
  31. Guimaraes MCS(*), Celeste BJ, Franco EL, Cuce LC, Belda W. Evaluation of serological diagnostic indices for mucocutaneous leishmaniasis: Immunofluorescence tests and enzyme-linked immunoassays for IgG, IgM, and IgA antibodies. Bulletin of the World Health Organization 67: 643-648, 1989.
  32. Marques LA(§), Franco EL, Brentani RR(*), Torloni H, Brentani MM, Silva-Neto JB. Independent prognostic value of laminin receptor expression in breast cancer survival. Cancer Research 50: 1479-1483, 1990.
  33. Campos-Filho N, Franco EL(*). Microcomputer-assisted multivariate survival data analysis using Cox's proportional hazards regression model. Computer Methods and Programs in Biomedicine 31: 81-87, 1990.
  34. Guimaraes MCS(*), Celeste BJ, Franco EL. Diagnostic performance indices for immunofluorescent tests and enzyme immunoassays of leishmaniasis sera from Northern and North-eastern Brazil. Bulletin of the World Health Organization 68: 39-43, 1990.
  35. Soto JC(*), Levy M, Allard R, Franco EL. Le SIDA et le contrôle des infections au Québec: étude des attitudes, des connaisances et des comportements des intervenants en santé dentaire. J. Santé Dent. Comm. Québec 3: 5-11, 1990.
  36. Franco EL. The sexually-transmitted disease model for cervical cancer: Incoherent epidemiologic findings and the role of misclassification of human Papillomavirus infection. Epidemiology 2: 98-106, 1991.
  37. Camargo B(§), Franco EL(*). Single-dose versus fractionated-dose dactinomycin in the treatment of Wilms’ tumor: Preliminary results of a clinical trial. Cancer 67: 2990-2996, 1991.
  38. Payment P(*), Richardson L, Siemiatycki J, Dewar R, Edwardes M, Franco EL. A randomized trial to evaluate the risk of gastrointestinal disease due to consumption of drinking water meeting current microbiological standards. American Journal of Public Health 81: 703-708, 1991.
  39. Payment P(*), Franco EL, Richardson L, Siemiatycki J. Gastrointestinal health effects associated with the consumption of drinking water produced by point-of-use domestic reverse-osmosis filtration units. Applied and Environmental Microbiology 57: 945-948, 1991.
  40. Franco EL(*), Kowalski LP, Kanda JL. Risk factors for second cancers of the upper respiratory and digestive systems: a case-control study. Journal of Clinical Epidemiology 44: 615-625, 1991.
  41. Franco EL(*), Kowalski LP. Design options for the study of second cancers. Journal of Clinical Epidemiology 44: 629-632, 1991.
  42. Petrilli AS(*§), Gentil F, Epelman S, Lopes LF, Bianchi A, Lopes A, Figueiredo M, Marques E, Consentino E, Prospero D, Camargo OP, Oliveira NR, Franco EL, Jaffe N. Increased survival, limb preservation, and prognostic factors for osteosarcoma. Cancer 68: 733-737, 1991.
  43. Franco EL(*), Camargo B, Saba L, Marques LA. Epidemiological and clinical correlations with genetic characteristics of Wilms' tumor: Results of the Brazilian Wilms’ Tumor Study Group. International Journal of Cancer 48: 641-646, 1991.
  44. Franco EL. Multiple cancers of the upper aero-digestive tract: The challenge of risk factor identification. Cancer Letters 60: 1-8, 1991.
  45. Franco EL. Viral etiology of cervical cancer: A critique of the evidence. Reviews of Infectious Diseases 13: 1195-1206, 1991.
  46. Kowalski LP(*§), Franco EL, Andrade J, Oliveira BV, Pontes PL. Prognostic factors in laryngeal cancer patients submitted to surgical treatment. Journal of Surgical Oncology 48: 87-95, 1991.
  47. Franco EL. Prognostic value of human Papillomavirus in the survival of cervical cancer patients: An overview of the evidence. Cancer Epidemiology, Biomarkers & Prevention 1: 499-504, 1992.
  48. Franco EL. Human Papillomavirus and the natural history of cervical cancer. Infections in Medicine 10: 57-64, 1993.
  49. Franco EL(*), Dib LL, Pinto DS, Lombardo V, Contesini H. Race and gender influences on the survival of patients with mouth cancer. Journal of Clinical Epidemiology 46: 37-46, 1993.
  50. Payment P(*), Franco EL, Siemiatycki J. Absence of relationship between health effects due to tap water consumption and drinking water quality parameters. Water Science and Technology 27: 3-4, 1993.
  51. Marques LA(§), Franco EL(*). Association between timing of surgery during menstrual cycle and prognosis in pre-menopausal breast cancer. International Journal of Cancer 53: 707-708, 1993.
  52. Soto JC(*), Levy M, Allard R, Franco EL. Determinants of AIDS preventive behaviour among dental professionals. Canadian Journal of Public Health 84: 128-131, 1993.
  53. Rapoport A(*§), Franco EL. Prognostic factors and relative risk in hypopharyngeal cancer - Related parameters concerning stage, therapeutics, and evolution. Sao Paulo Medical Journal 111: 337-343, 1993.
  54. Payment P(*), Franco EL. Clostridium perfringens and somatic coliphages as indicators of the efficiency of drinking water treatment for viruses and protozoan cysts. Applied and Environmental Microbiology 59: 2418-2424, 1993.
  55. Coelho FRG(*§), Kowalski LP, Franco EL, Contesini H, Zeferino LC. Analise de sobrevida de uma amostra de 2000 casos de cancer tratados no Hospital A.C. Camargo de 1980 a 1987. Acta Oncologica Brasileira 13: 8-16, 1993.
  56. Siemiatycki J(*), Dewar R, Desy M, Krewski D, Franco E, Richardson L. Are the apparent effects of cigarette smoking on lung and bladder cancers due to uncontrolled confounding by occupational exposures? Epidemiology 5: 57-65, 1994.
  57. Chammas R(*), Cella N, Marques LA, Brentani RR, Hynes NE, Franco EL. B1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Research 54: 306-307, 1994.
  58. Kowalski LP(*§), Franco EL, Fava AS, Andrade J, Oliveira BV, Curado MP, Torloni H. Lateness of diagnosis of oral and oropharyngeal carcinoma: Factors related to the tumour, the patient, and health professionals. European Journal of Cancer (Part B: Oral Oncology) 30B: 167-173, 1994.
  59. Camargo B(§), Franco EL(*). A randomized clinical trial of single-dose versus fractionated-dose dactinomycin in the treatment of Wilms’ tumor: Results after extended follow-up. Cancer 73: 3081-3086, 1994.
  60. Franco EL. Cancer epidemiology: substance and methods (invited review). Journal of the Brazilian Association for the Advancement of Science (Ciencia e Cultura) 46: 46-62, 1994.
  61. Pintos J(§), Franco EL(*), Oliveira BV, Kowalski LP, Curado MP, Dewar R. Maté, coffee, and tea consumption and risk of cancers of the upper aerodigestive tract in Southern Brazil. Epidemiology 5: 583-590, 1994.
  62. Payment P(*), Franco EL, Fout S. Incidence of Norwalk virus infections during a prospective epidemiological study of drinking water related gastrointestinal illness. Canadian Journal of Microbiology 40: 805-809, 1994.
  63. Franco E(*), Villa LL, Rahal P, Ruiz A. Molecular variant analysis as an epidemiological tool to study persistence of cervical human papillomavirus infection. Journal of the National Cancer Institute 86: 1558-1559, 1994.
  64. Sharpe C(§), Franco E(*), Camargo B, Lopes L, Barreto J, Johnsson R, Mauad M. Parental exposures to pesticides and risk of Wilms' tumor in Brazil. American Journal of Epidemiology 141: 210-217, 1995.
  65. Ferenczy A(*), Choukroun D, Falcone T, Franco EL. The effect of cervical loop electrosurgical excision on subsequent pregnancy outcome: North-American experience. American Journal of Obstetrics & Gynecology 172: 1246-1250, 1995.
  66. Franco EL. Editorial: Cancer causes revisited: Human papillomavirus and cervical neoplasia. Journal of the National Cancer Institute 87: 779-780, 1995. (peer-reviewed)
  67. Franco EL(*), Villa LL, Ruiz A, Costa MC. Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic risk types. Journal of Infectious Diseases 172: 756-763, 1995.
  68. Siemiatycki J(*), Krewski D, Franco E, Kaiserman M. Associations between cigarette smoking and each of 21 types of cancer: A multi-site case-control study. International Journal of Epidemiology 24: 504-514, 1995.
  69. Kowalski LP(*§), Franco EL, Andrade J. Factors influencing regional lymph node metastasis from laryngeal carcinoma. Annals of Otology, Rhinology & Laryngology 104: 442-447, 1995.
  70. Foulkes WD, Brunet JS, Kowalski LP, Narod SA, Franco EL(*). Family history of cancer is a risk factor for squamous cell carcinoma of the head and neck in Brazil: a case-control study. International Journal of Cancer 63: 769-773, 1995.
  71. Sharpe CR(§), Franco EL(*). Etiology of Wilms' tumor. Epidemiologic Reviews 17: 415-432, 1995.
  72. Franco E(*), Bergeron J, Villa L, Arella M, Richardson L, Arseneau J, Stanimir G. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study. Cancer Epidemiology, Biomarkers & Prevention 5: 271-275, 1996.
  73. Franco EL. Mechanistic reasoning in socio-behavioral epidemiology: The influence of race and ethnicity on cancer survival. Epidemiology 7: 326-327, 1996.
  74. Sharpe C(§), Franco E(*). Use of dipyrone during pregnancy and risk of Wilms' tumor. Epidemiology 7: 533-535, 1996.
  75. Ferenczy A(*), Franco E, Arseneau J, Wright T, Richart R. Diagnostic performance of Hybrid Capture human papillomavirus deoxyribonucleic acid assay combined with liquid-based cytologic study. American Journal of Obstetrics & Gynecology 175: 651-656, 1996.
  76. Ferenczy A(*), Robitaille J, Franco E, Arseneau J, Richart R, Wright T. Conventional cervical cytologic smears vs ThinPrep smears: A paired comparison study on cervical cytology. Acta Cytologica 40: 1136-1142, 1996.
  77. Payment P(*), Siemiatycki J, Richardson L, Renaud G, Franco E, Prevost M. A prospective epidemiological study of gastrointestinal health effects due to the consumption of drinking water. International Journal of Environmental Health Research 7: 5-31, 1997.
  78. Ferenczy A(*), Gelfand M, Franco E, Mansour N. Human papillomavirus infection in postmenopausal women with and without hormone therapy. Obstetrics and Gynecology 90: 7-11, 1997.
  79. Coelho FR(*§), Franco EL, Kowalski LP, Zeferino LC, Brentani MM, Abrão FS. Carcinoma espinocelular do colo uterino submetido a cirurgia radical isolada ou em combinação com radioterapia: Análise multivariada de fatores prognósticos. Acta Oncologica Brasileira 17: 68-87, 1997.
  80. Coutlée F(*), Mayrand M, Provencher D, Franco E. The future of hpv testing in clinical laboratories and applied virology research. Clinical and Diagnostic Virology 8: 123-141, 1997.
  81. Mandeville R(*), Franco E, Ghali S, Nadon L, Rocheleau N, Mercier G, Désy M, Gaboury L. Evaluation of the potential carcinogenicity of 60 Hz linear sinusoidal continuous-wave magnetic fields in Fischer F344 rats. FASEB Journal 11: 1127-1136, 1997.
  82. Bruneau J(*§), Lamothe F, Franco E, Lachance N, Désy M, Soto J, Vincelette J. High rates of HIV-1 infection among drug users participating in needle exchange programs in Montreal: Results of a cohort study. American Journal of Epidemiology 146: 994-1002, 1997.
  83. Bruneau J(*§), Franco E, Lamothe F. Assessing harm reduction strategies: The dilemma of observational studies. American Journal of Epidemiology 146: 1007-1010, 1997.
  84. Allison P(§), Franco E, Feine J(*). Predictors of professional diagnostic delays for upper aerodigestive tract carcinoma. European Journal of Cancer (Part B: Oral Oncology) 34:127-132, 1998.
  85. Allison P(§), Franco E, Black M, Feine J(*). The role of professional diagnostic delays in the prognosis of upper aerodigestive tract carcinoma. European Journal of Cancer (Part B: Oral Oncology) 34: 147-153, 1998.
  86. Velly AM(§), Franco EL(*), Schlecht N, Pintos J, Kowalski LP, Oliveira BV, Curado MP. Relationship between dental factors and risk of upper aero-digestive tract cancer. European Journal of Cancer (Part B: Oral Oncology) 34: 284-291, 1998.
  87. Nguyen TN(§), Bourdeau JL, Ferenczy A(*), Franco EL. Clinical significance of histiocytes in the detection of endometrial adenocarcinoma and hyperplasia. Diagnostic Cytopathology 19: 89-93, 1998.
  88. Pintos J(§), Franco EL(*), Kowalski LP, Oliveira BV, Curado MP. Use of wood stoves and risk of cancers of the upper aero-digestive tract: a case-control study. International Journal of Epidemiology 27: 936-940, 1998.
  89. Coelho FR(§*), Franco EL, Kowalski LP, Abrao FS. Preoperative irradiation therapy and radical hysterectomy: prognostic value of tumor regression after initial irradiation of squamous cell carcinoma of the cervix. Sao Paulo Medical Journal (Revista Paulista de Medicina). 116: 1700-1709, 1998.
  90. Franco EL(*), Rohan TE, Villa LL. Epidemiologic evidence and human papillomavirus infection as a necessary cause of cervical cancer. Journal of the National Cancer Institute 91: 506-511, 1999.
  91. Pintos J(§), Franco EL(*), Bergeron J, Arella M, Black M. Human papillomavirus and prognoses of patients with cancers of the upper aero-digestive tract. Cancer 85: 1903-1909, 1999.
  92. Sharpe C(§), Franco E(*), Camargo B, Lopes L, Barreto J, Johnsson R, Mauad M. The influence of parental age on the risk of Wilms’ tumor. Paediatric & Perinatal Epidemiology 13:138-143, 1999.
  93. Coutlée F(*), Gravitt P, Richardson H, Hankins C, Franco E, Lapointe N, Voyer H. Nonisotopic detection and typing of human papillomavirus DNA in genital samples by the line blot assay. Journal of Clinical Microbiology 37: 1852-1857, 1999.
  94. Schlecht N(§), Franco EL(*), Pintos J, Kowalski LP. Effect of smoking cessation and tobacco type on the risk of cancers of the upper aero-digestive tract in Brazil. Epidemiology 10: 412-418, 1999.
  95. Franco EL(*), Ferenczy A. Assessing gains in diagnostic utility when human papillomavirus testing is used as a Pap smear adjunct for triaging women with cervical cytological abnormalities. American Journal of Obstetrics & Gynecology 181: 382-386, 1999.
  96. Franco EL(*), Villa LL, Sobrinho J, Prado JM, Rousseau MC, Désy M, Rohan TE. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. Journal of Infectious Diseases 180: 1415-1423, 1999.
  97. Franco E(*), Villa L, Rohan T, Ferenczy A, Petzl-Erler M, Matlashewski G. Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Pan American Journal of Public Health 6: 223-233, 1999.
  98. Schlecht N(§), Franco EL(*), Pintos J, Negassa A, Kowalski LP, Oliveira BV, Curado MP. Interaction between tobacco and alcohol consumption on the risk of cancers of the upper aero-digestive tract in Brazil. American Journal of Epidemiology 150: 1129-1137, 1999.
  99. Mandeville R(*), Franco E, Sidrac-Ghali S, Paris-Nadon L, Rocheleau N, Mercier G, Desy M, Devaux C, Gaboury L. Evaluation of the potential promoting effect of 60 Hz magnetic fields on N-ethyl-N-nitrosourea induced neurogenic tumors in female F344 rats. Bioelectromagnetics 21: 84-93, 2000.
  100. Richardson H(§), Franco E(*), Pintos J, Bergeron J, Arella M, Tellier P. Determinants of low-risk and high-risk cervical human papillomavirus infections in Montreal University students. Sexually Transmitted Diseases 27: 79-86, 2000.
  101. Rousseau MC(§), Franco EL(*), Villa LL, Sobrinho J, Termini L, Prado JM, Rohan TE. A cumulative case-control study of risk factor profiles for oncogenic and non-oncogenic cervical human papillomavirus infections. Cancer Epidemiology, Biomarkers & Prevention 9: 469-476, 2000.
  102. Makni H(§), Franco E(*), Kaiano J, Villa L, Lebrecque S, Dudley R, Storey A, Matlashewski G. P53 polymorphism in codon 72 and risk of HPV-induced cervical cancer: effect of inter-laboratory variation. International Journal of Cancer 87: 528-533, 2000.
  103. Klam S(§), Arseneau J, Mansour N, Franco E, Ferenczy A(*). Comparison of endocervical curettage and endocervical brushing. Obstetrics & Gynecology 96: 90-94, 2000.
  104. Ratnam S, Franco EL(*), Ferenczy A. Human papillomavirus testing for primary screening of cervical cancer precursors. Cancer Epidemiology, Biomarkers & Prevention 9, 945-951, 2000.
  105. Brogly SB(§), Bruneau J(§*), Lamothe F, Vincelette J, Franco EL. Risk behaviour change and HIV infection among injection drug users in Montreal. AIDS 14: 2575-2582, 2000.
  106. Maciag PC(§), Schlecht NF, Souza PA, Franco EL, Villa LL(*), Petzl-Erler ML. Major histocompatibility complex class II polymorphisms and risk of cervical cancer and human papillomavirus infection in Brazilian women. Cancer Epidemiology, Biomarkers and Prevention 9: 1183-1191, 2000.
  107. Villa LL(*), Sichero L, Rahal P, Caballero O, Ferenczy A, Rohan T, Franco EL. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. Journal of General Virology 81, 2959–2968, 2000.
  108. Ferenczy A, Franco EL. Cervical-cancer screening beyond the year 2000. Lancet Oncology 2: 27-32, 2001.
  109. Bruneau J(§*), Lamothe F, Soto, J, Lachance N, Vincelette J, Vassal A, Franco E. Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal 164: 767-776, 2001.
  110. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. Canadian Medical Association Journal 164: 1017-1025, 2001.
  111. Rohan TE(*), Burk RD, Franco EL. Towards a reduction of the global burden of cervical cancer. Clinical Journal of Women's Health 1: 103-106, 2001.
  112. Yoskovitch A(§), Frenkiel S, Franco E, Coutlée F, Nachtigal D, Rochon L. Analysis of human papillomavirus in Schneiderian papillomas as compared to chronic sinusitis and normal nasal mucosa. Journal of Otolaryngology 30: 167-172, 2001.
  113. Schlecht NF(§), Pintos J, Kowalski LP, Franco EL(*).Effect of type of alcoholic beverage on the risks of upper aerodigestive tract cancers in Brazil. Cancer Causes & Control 12: 579-587, 2001.
  114. Kornegay JR(*), Shepard AP, Hankins C, Franco E, Lapointe N, Richardson H, Canadian Women's HIV Study Group, Coutleé F. Nonisotopic detection of human papillomavirus dna in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format. Journal of Clinical Microbiology 39: 3530–3536, 2001.
  115. Healey SM(§), Aronson KJ, Mao Y, Schlecht NF, Mery LS, Ferenczy A, Franco EL(*). Oncogenic human papillomavirus infection and cervical lesions in aboriginal women in Nunavut, Canada. Sexually Transmitted Diseases 28: 694-700, 2001.
  116. Rousseau MC(§), Pereira JS, Prado JCM, Villa LL, Rohan TE, Franco EL(*). Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection. Journal of Infectious Diseases 184:1508–1517, 2001.
  117. Schlecht NF(§), Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. Journal of the American Medical Association 286: 3106-3114, 2001.
  118. Schlecht NF(§), Franco EL(*), Rohan TE, Kjær SK, Schiffman M, Moscicki AB, Duffy SW, for the MARSH International Collaborative Group. Repeatability of sexual history in longitudinal studies: determinants of reporting error at follow-up interviews. Journal of Epidemiology and Biostatistics 6: 393-407, 2001.
  119. Ferenczy A(*), Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncology 3: 11–16, 2002.
  120. Brogly SB(§), Bruneau J, Lamothe F, Vincelette J, Franco EL. HIV positive notification and behaviour changes in Montreal injection drug users. AIDS Education and Prevention 14: 17-28, 2002.
  121. Coutleé F(*), Gravitt P, Kornegay JR, Hankins C, Richardson H, Lapointe N, Voyer H, Canadian Women's HIV Study Group, Franco E. Use of PGMY primers in L1 consensus PCR improves detection of human papillomavirus DNA in genital samples. Journal of Clinical Microbiology 40: 902-907, 2002.
  122. Carvalho AL(§), Pintos J, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Predictive factors for diagnosis of advanced-stage squamous cell carcinoma of the head and neck. Archives of Otolaryngology and Head & Neck Surgery 128: 313-318, 2002.
  123. Maciag PC(§), Schlecht NF, Souza PSA, Rohan TE, Franco EL, Villa LL(*). Polymorphisms of the human leukocyte antigen DRB1 and DQB1 genes and the natural history of human papillomavirus infection. Journal of Infectious Diseases 186: 164–172, 2002.
  124. Macaskill P(*), Walter SD, Irwig L, Franco EL. Assessing the gain in diagnostic performance when combining two diagnostic tests. Statistics in Medicine 21: 2527-2546, 2002.
  125. Tran-Thanh D, Koushik A, Provencher D, Drouin P, Dubuc-Lissoir J, Gauthier P, Allaire G, Kornegay J, Franco E, Coutlée F(*). Detection of Human Herpes Virus type 6 DNA in precancerous lesions of the uterine cervix. Journal of Medical Virology 68: 606–610, 2002.
  126. Franco EL, Duarte-Franco E, Rohan TE. Evidence-based policy recommendations on cancer screening and prevention. Cancer Detection and Prevention 26: 350-361, 2002.
  127. Nishimoto IN(§), Pintos J, Schlecht NF, Torloni H, Carvalho AL, Kowalski LP, Franco EL(*). Assessment of control selection bias in a hospital-based case-control study of upper aero-digestive tract cancers. Journal of Cancer Epidemiology and Prevention (formerly J Epidemiol Biostat) 7: 131-141, 2002.
  128. Schlecht NF(§), Trevisan A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Viral load as a predictor of the risk of cervical intraepithelial neoplasia. International Journal of Cancer 103: 519-524, 2003.
  129. Li J(§), Rousseau MC, Franco EL, Ferenczy A(*). Is colposcopy warranted in women with external anogenital warts? Journal of Lower Genital Tract Disease 7: 22-28, 2003.
  130. Tran-Thanh D, Provencher D, Koushik A, Duarte-Franco E, Kessous A, Drouin P, Wheeler C, Dubuc-Lissoir J, Gauthier P, Allaire G, Vauclair R, DiPaolo J, Gravitt P, Franco E, Coutlée F(*). Herpes Simplex Virus type II is not a cofactor to human papillomavirus in cancer of the uterine cervix. American Journal of Obstetrics & Gynecology 188: 129-134, 2003.
  131. Nonnenmacher B(§*), Pintos J, Bozzetti MC, Mielzinska-Lohnas I, Lorincz AT, Ikuta N, Schwartsmann G, Villa LL, Schiller JT, Franco E. Epidemiologic correlates of antibody response to human papillomavirus among women at low risk of cervical cancer. International Journal of STD & AIDS 14: 258–265, 2003.
  132. Brogly S(§), Mercier C, Bruneau J(§*), Palepu A, Franco E. Towards more effective public health programming for injection drug users: development and evaluation of the injection drug user quality of life scale. Substance Use & Misuse 38: 965-992, 2003.
  133. Franco EL. Primary screening of cervical cancer with human papillomavirus tests. Journal of the National Cancer Institute Monographs 31: 89-96, 2003.
  134. Richardson H(§), Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlée F, Franco EL(*). The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiology, Biomarkers & Prevention 12: 485-490, 2003.
  135. Rousseau MC(§), Villa LL, Costa MC, Abrahamowicz M, Rohan TE, Franco EL(*). Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytological abnormalities. Sexually Transmitted Diseases 30: 581-587, 2003.
  136. Goldie SJ(*), Grima D, Kohli M, Wright TC, Weinstein M, Franco E. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine. International Journal of Cancer 106: 896-904, 2003.
  137. Schlecht NF(§), Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JCM, Ferenczy A, Rohan TE, Villa LL, Franco EL(*). Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia. Journal of the National Cancer Institute 95: 1336-1343, 2003.
  138. Ferenczy A(*), Coutlée F, Franco E, Hankins C. Human papillomavirus and HIV coinfection and the risk of neoplasias of the lower genital tract: a review of recent developments. Canadian Medical Association Journal 169: 431-434, 2003.
  139. Rousseau MC(§), Abrahamowicz M, Villa LL, Costa MC, Rohan TE, Franco EL(*). Predictors of cervical coinfection with multiple human papillomavirus types. Cancer Epidemiology, Biomarkers & Prevention 12: 1029-1037, 2003.
  140. Schlecht NF(§), Platt RW, Negassa A, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Modeling the time dependence of the association between human papillomavirus infection and cervical cancer precursor lesions. American Journal of Epidemiology 158: 878–886, 2003.
  141. Rohan TE(*), Burk RD, Franco EL. Toward a reduction of the global burden of cervical cancer. American Journal of Obstetrics & Gynecology 189: S37-S39, 2003.
  142. Giuliano AR(*), Siegel EM, Roe DJ, Ferreira S, Baggio ML, Galan L, Duarte-Franco E, Villa LL, Rohan TE, Marshall JR, Franco EL. Dietary intake and risk of persistent human papillomavirus (HPV) infection: The Ludwig-McGill HPV natural history study. Journal of Infectious Diseases 15: 1508-1516, 2003.
  143. Franco E, Schlecht N, Saslow D. The epidemiology of cervical cancer. Cancer Journal 9: 348-359, 2003.
  144. Monsonego J, Bosch FX, Coursaget P, Cox JT, Franco E, Frazer I, Sankaranarayanan R, Schiller J, Singer A, Wright T, Kinney W, Meijer C, Linder J. Cervical cancer control, priorities and new directions. International Journal of Cancer 108: 329-333, 2004.
  145. Mahmud S(§*), Franco E, Aprikian A. Prostate cancer and use of non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis. British Journal of Cancer 90: 93-99, 2004.
  146. Roy MC(§), Mayrand MH, Franco EL, Arseneau J, Ferenczy A(*). Electrofulguration for low-grade squamous intraepithelial lesions of the cervix (CIN1). Journal of Lower Genital Tract Disease 8: 10-15, 2004.
  147. Aho J, Kornegay JR, Healey S, Roger M, Dion F, Gaudreault D, Shepard AP, Franco EL, Coutlée F(*). Evaluation of a convenient enzyme immunoassay to assess the quality of genital specimens submitted for the detection of human papillomavirus DNA by consensus PCR. Journal of Clinical Virology 29: 127-133, 2004.
  148. Koushik A(§), Platt RW, Franco EL(*). P53 codon 72 polymorphism and cervical neoplasia: A meta-analysis review. Cancer Epidemiology, Biomarkers & Prevention 13: 11-22, 2004.
  149. Pinto AP(*§), Schlecht NF, Pintos J, Kaiano J, Franco EL, Crum CP, Villa LL. Prognostic significance of lymph node variables and human papillomavirus DNA in invasive vulvar carcinoma. Gynecologic Oncology 92: 856-865, 2004.
  150. Goldie SJ(*), Kohli M, Grima D, Weinstein M, Wright TC, Bosch FX, Franco E. Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine. Journal of the National Cancer Institute 96: 604-615, 2004.
  151. Bruneau J(§*), Brogly SB, Tyndall MW, Lamothe F, Franco EL. Intensity of drug injection as a determinant of sustained injection cessation among chronic drug users: the interface with social factors and service utilization. Addiction 99: 727–737, 2004.
  152. Vuong T(*), Franco E, Lehnert S, Lambert C, Portelance L, Nasr E, Faria S, Hay J, Larsson S, Shenouda G, Souhami L, Wong F, Freeman C. Silver leaf nylon dressing to prevent radiation dermatitis in patients undergoing chemotherapy and external beam radiotherapy to the perineum. International Journal of Radiation Oncology, Biology and Physics 59: 809-814, 2004.
  153. Duarte-Franco E(*), Franco EL. Cancer of the Uterine Cervix. BMC Womens Health 4 (Suppl 1): S13 (1-10), 2004.
  154. Duarte-Franco E(*), Franco EL. Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers. BMC Womens Health 4 (Suppl 1):S14 (1-9), 2004.
  155. Siegel EM, Craft N, Roe D, Duarte-Franco E, Villa LL, Franco EL, Giuliano AR(*). Temporal variation and identification of factors associated with endogenous retinoic acid isomers in serum from Brazilian women. Cancer Epidemiology, Biomarkers & Prevention 13: 1693-1703, 2004.
  156. Harper DM(*), Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, Zahaf T, Innis B, Naud P, De Carvalho NS, Roteli-Martins CM, Teixeira J, Blatter MM, Korn AP, Quint W, Dubin G; GlaxoSmithKline HPV Vaccine Study Group. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial. Lancet 364: 1757-1765, 2004.
  157. Healey SM(§*), Aronson K, Mao Y, Franco EL. Human papillomavirus and cervical dysplasia in Nunavut: prelude to a screening strategy. International Journal of Circumpolar Health. 63 Suppl 2:199-201, 2004.
  158. Dang-Tan T(§), Mahmud S, Puntoni R, Franco EL(*). Polio vaccines, Simian Virus 40, and human cancer: The epidemiologic evidence for a causal association. Oncogene 23: 6535-6540, 2004.
  159. Franco EL, Correa P, Santella RM, Wu X, Goodman SN, Petersen GM. Role and limitations of epidemiology in establishing a causal association. Seminars in Cancer Biology 14: 413-426, 2004.
  160. Stuart G(*), Taylor G, Bancej CM, Beaulac J, Colgan T, Franco EL, Kropp RY, Lotocki R, Mai V, McLachlin CM, Onysko J, Martin RE. Report of the 2003 Pan-Canadian Forum on Cervical Cancer Prevention and Control. Journal of Obstetrics and Gynaecology of Canada 26: 1004-1014, 2004.
  161. Sichero L, Franco EL, Villa LL(*). Different p105 promoter activities among natural variants of human papillomavirus type 18. Journal of Infectious Diseases 191: 739-742, 2005.
  162. Spence A(§), Franco E, Ferenczy A(*). The role of human papillomaviruses in cancer: evidence to date. American Journal of Cancer 4: 49-64, 2005.
  163. Franco EL, Harper DM. Vaccination against human papillomavirus infection: A new paradigm in cervical cancer control. Vaccine 23: 2388-2394, 2005.
  164. Richardson H(§), Abrahamowicz M, Tellier P, Kelsall G, du Berger R, Ferenczy A, Coutlée F, Franco EL(*). Modifiable risk factors associated with clearance of type-specific cervical human papillomavirus infections in a cohort of university students. Cancer Epidemiology Biomarkers & Prevention 14: 1149-1156, 2005.
  165. Coutlée F(*), Rouleau D, Ferenczy A, Franco E. The laboratory diagnosis of genital human papillomavirus infections. Canadian Journal of Infectious Diseases and Medical Microbiology 16: 83-91, 2005.
  166. Koushik A(§), Ghosh A, Duarte-Franco E, Forest P, Voyer H, Matlashewski G, Coutlée F, Franco EL(*), for the Biomarkers of Cervical Cancer Risk (BCCR) Study Team. The p53 codon 72 polymorphism and risk of high-grade cervical intraepithelial neoplasia. Cancer Detection and Prevention 29: 307-316, 2005.
  167. Kowalski LP(§*), Nishimoto IN, Carvalho AL, Oliveira BV, Curado MP, Fava AS, Torloni H, Franco EL. Looking beyond tobacco and alcohol: The role of lifestyle and other environmental risk factors for laryngeal cancer. Applied Cancer Research 25: 10-19, 2005.
  168. Vilela LD(§), Nicolau B, Mahmud S, Edgar L, Hier M, Black M, Franco EL, Allison P(*). Comparison of psychosocial outcomes in head and neck cancer patients receiving a coping strategies intervention and control subjects receiving no intervention. Journal of Otolaryngology 35: 88-96, 2006.
  169. Burchell AN(§), Richardson H, Mahmud SM, Trottier H, Tellier PP, Hanley J, Coutlée F, Franco EL(*). Modeling the sexual transmissibility of human papillomavirus infection using stochastic computer simulation and empirical data from a cohort study of young women in Montreal, Canada. American Journal of Epidemiology 163:534-543, 2006.
  170. Mahmud SM (§*), Tanguay S, Bégin LR, Franco EL, Aprikian AG. Non-steroidal anti-inflammatory drug use and prostate cancer in a high-risk population. European Journal of Cancer Prevention 15: 158-164, 2006.
  171. Monsonego J(*), Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, Bianchi A, Franco E. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. International Journal of Gynecological Cancer 16:591-598, 2006.
  172. Mayrand MH(§), Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL(*), for the CCCaST Study Group. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: Design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). International Journal of Cancer 119:615-623, 2006.
  173. Goffin F, Mayrand MH, Gauthier P, Alobaid A, Lussier C, Provencher D, Drouin P, Franco EL, Coutlée F(*).High-risk human papillomavirus infection of the genital tract of women with a previous history or current high-grade vulvar intraepithelial neoplasia. Journal of Medical Virology 78:814-819, 2006.
  174. Harper DM(*), Franco EL, Wheeler CM, Moscicki AB, Romanowski B, Roteli-Martins CM, Jenkins DD, Schuind A, Clemens SAC, Dubin G. Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18. Follow-up from a randomized controlled trial in young women. Lancet 367: 1247-1255, 2006.
  175. Alotaibi L, Provost N, Gagnon S, Franco EL, Coutlée F(*). Diversity of cutaneous human papillomavirus types in individuals with and without skin lesion. Journal of Clinical Virology 36: 133-140, 2006.
  176. Coutlée F(*), Rouleau D, Petignat P, Ghattas G, Kornegay JR, Schlag P, Boyle S, Hankins C, Vézina S, Coté P, Macleod J, Voyer H, Forest P, Walmsley S, Franco E. Enhanced Detection and typing of Human Papillomavirus DNA in Anogenital Samples with PGMY primers and the Linear Array HPV Genotyping Test. Journal of Clinical Microbiology 44: 1998-2006, 2006.
  177. Trottier H(§), Franco EL(*). The epidemiology of genital human papillomavirus infection. Vaccine 24: S1/4-15, 2006.
  178. Sangwa-Lugoma G(§), Mahmud S, Nasr S, Liaras J, Kayembe P, Tozin R, Drouin P, Lorincz A, Ferenczy A, Franco EL(*). Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. International Journal of Cancer 119: 1389-1395, 2006.
  179. Trottier H(§), Mahmud S, Costa MC, Sobrinho JP, Duarte-Franco E, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiology, Biomarkers and Prevention 15: 1274-1280, 2006.
  180. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Ferreira S, Tellier P, Simao J, Matlashewski G, Roger M, Franco EL, Coutlée F(*). Human papillomavirus type 33 polymorphisms and high-grade squamous intraepithelial lesions of the uterine cervix. Journal of Infectious Diseases 194: 886-894, 2006.
  181. Schlecht NF(§), Trevisan A, Baggio ML, Galan L, Duarte-Franco E, Greenberg MD, Rohan TE, Ferenczy A, Villa LL, Franco EL(*). Lack of agreement between cervicography and cytology and the effect of human papillomavirus infection and viral load. Journal of Lower Genital Tract Disease 10: 229-237, 2006.
  182. Frazer IH(*), Cox JT, Mayeaux EJ, Franco EL, Moscicki AB, Palefsky J, Ferris D, Ferenczy A, Villa L. Advances in prevention of cervical cancer and other human papillomavirus-related diseases. Pediatric Infectious Disease Journal 25: S65–S81, 2006.
  183. Burchell AN(§), Winer RL, Sanjosé S, Franco EL. Epidemiology and transmission dynamics of genital human papillomavirus infection. Vaccine 24S3: 52-61, 2006.
  184. Franco EL(*), Cuzick J, Hildesheim A, Sanjose S. Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 24S3: 171-177, 2006.
  185. Franco EL(*), Bosch FX, Cuzick J, Schiller J, Garnett G, Meheus A, Wright TC. Knowledge gaps and priorities for research on prevention of HPV infection and cervical cancer. Vaccine 24S3: 242-249, 2006.
  186. Wright TC, Bosch FX, Franco EL, Cuzick J, Schiller J, Garnett G, Meheus A. HPV Vaccines and screening in the prevention of cervical cancer: Conclusions from a 2006 Workshop of International Experts. Vaccine 24S3: 251-261, 2006.
  187. Trottier H(§), Franco EL. Human papillomavirus and cervical cancer: burden of illness and basis for prevention. American Journal of Managed Care 12: S462-472, 2006.
  188. Siegel EM, Craft N, Duarte-Franco EF, Villa LL, Franco EL, Giuliano AR(*). Associations between serum carotenoids and tocopherols and type-specific HPV persistence: the Ludwig-McGill Cohort Study. International Journal of Cancer 120: 672–680, 2007.
  189. Gagnon S, Hankins C, Money D, Pourreaux K, Canadian Women's HIV Study Group, Franco EL, Coutlée F(*). Polymorphism of the L1 capsid gene and persistence of human papillomavirus type 52 infection in women at high-risk or infected by HIV. Journal of Acquired Immunodeficiency Syndrome 44: 61-65, 2007.
  190. Kohli M, Ferko N(*), Martin A, Franco EL, Jenkins D, Gallivan, S, Sherlaw-Johnson C, Drummond M. Estimating the long-term impact of a prophylactic human papillomavirus (HPV) 16/18 vaccine on the burden of cervical cancer in the UK. British Journal of Cancer 96: 143-150, 2007.
  191. Sichero L, Ferreira S, Trottier H, Duarte-Franco E, Ferenczy A, Franco EL, Villa LL(*). High grade cervical lesions are caused preferentially by non-European variants of HPVs 16 and 18. International Journal of Cancer 120: 1763-1768, 2007.
  192. Al-Qahtani K(§), Brousseau V, Paczesny D, Domanowski G, Hamid Q, Hier M, Black M, Franco E, Kost K. Koilocytosis in oral squamous cell carcinoma: what does it mean? Journal of Otolaryngology 36: 26-31, 2007.
  193. Schaffer A(§), Koushik A, Trottier H, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Pollak M, Franco EL(*). Insulin-like growth factor-I and risk of high-grade cervical intraepithelial neoplasia. Cancer Epidemiology, Biomarkers and Prevention 16: 716-722, 2007.
  194. Petignat P(*), Faltin DL, Bruchim I, Tramèr MR, Franco EL, Coutlée F. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysis. Gynecologic Oncology 105: 530-535, 2007.
  195. Mahmud S(§), Robinson K, Richardson H, Tellier PP, Ferenczy A, Roger M, Coutlée F, Franco EL(*). HLA polymorphisms and cervical human papillomavirus infection in a cohort of Montreal university students. Journal of Infectious Diseases 196: 82–90, 2007.
  196. Franco EL, Ferenczy A. Cervical cancer screening following the implementation of prophylactic human papillomavirus vaccination. Future Oncology 3: 319-327, 2007.
  197. Brogly SB(*), Watts DH, Ylitalo N, Franco EL, Seage III GR, Oleske J, Eagle M, Van Dyke R. Reproductive health of adolescent girls perinatally infected with HIV. American Journal of Public Health 97: 1047-1052, 2007.
  198. Kim JJ(*), Kuntz KM, Stout NK, Mahmud S, Villa LL, Franco EL, Goldie SJ. Multi-Parameter Calibration of a Natural History Model of Cervical Cancer. American Journal of Epidemiology 166:137-150, 2007.
  199. Ferenczy A(*), Franco EL. Prophylactic human papillomavirus vaccines: Potential for sea change. Expert Reviews on Vaccines 6: 511-525, 2007.
  200. Goldie SJ(*), Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O’Shea MKH, Bosch FX, Sanjosé S, Franco EL. Cost-effectiveness of HPV 16,18 Vaccination in Brazil. Vaccine 25: 6257-6270, 2007.
  201. Dang-Tan T(§), Franco EL(*). Diagnosis delays in childhood cancer: A review. Cancer 110: 703-713, 2007.
  202. Spence A(§), Goggin P, Franco EL(*). Process of care failures in invasive cervical cancer: Systematic review and meta-analysis. Preventive Medicine 45:93-106, 2007.
  203. Mahmud SM(§), Koushik A, Duarte-Franco E, Costa J, Fontes G, Bicho M, Coutlée F, Franco EL(*). Haptoglobin phenotype and risk of cervical neoplasia: a case-control study. Clinica Chimica Acta 385: 67-72, 2007.
  204. Khouadri S, Villa LL, Gagnon S, Koushik A, Richardson H, Matlashewski G, Roger M, Ferenczy AS, Franco EL, Coutlée F(*). Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix. International Journal of Cancer 121: 2674–2681, 2007.
  205. Mayrand MH(§), Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutlée F, Franco EL(*), for the CCCaST Study Group. Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. New England Journal of Medicine 357: 1579-1588, 2007.
  206. Coutlée F(*), Rouleau D, Ghattas G, Hankins C, Vézina S, Coté P, Macleod J, Pokomandy A, Money D, Walmsley S, Voyer H, Brassard P, Franco E. Confirmatory real-time PCR assay for human papillomavirus (HPV) type 52 infection in anogenital specimens screened for HPV infection with the linear array HPV genotyping test. Journal of Clinical Microbiology 45: 3821-3823, 2007.
  207. Pintos J(§), Black MJ, Sadeghi N, Ghadirian P, Zeitouni AG, Viscidi RP, Herrero R, Coutlée F, Franco EL(*). Human papillomavirus infection and oral cancer: A case-control study in Montreal, Canada. Oral Oncology 44: 242-250, 2008.
  208. Franco EL, Cuzick J. Cervical cancer screening following prophylactic human papillomavirus vaccination. Vaccine 26S: A16-A23, 2008.
  209. Ades S(§), Koushik A, Duarte-Franco E, Mansour N, Arseneau J, Provencher D, Gilbert L, Gotlieb W, Ferenczy A, Coutlée F, Roger M, Franco EL(*). Selected class i and class ii hla alleles and haplotypes and risk of high-grade cervical intraepithelial neoplasia. International Journal of Cancer 122: 2820-2826, 2008.
  210. Trottier H(§), Mahmud S, Prado JCM, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL(*). Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. Journal of Infectious Diseases 197:1436-1447, 2008.
  211. Azizi N, Brazete J, Hankins C, Money D, Fontaine J, Koushik A, Rachlis A, Pourreaux K, Ferenczy A, Franco EL, Coutlée F. Influence of human papillomavirus type 16 (HPV-16) E2 polymorphism on quantification of HPV-16 episomal and integrated DNA in cervicovaginal lavages from women with cervical intraepithelial neoplasia. Journal of General Virology 89: 1716-1728, 2008.
  212. Dang-Tan T(§), Trottier H, Mery LS, Morrison HI, Barr RD, Greenberg ML, Franco EL(*). Delays in Diagnosis and Treatment among Children and Adolescents with Cancer in Canada. Pediatric Blood & Cancer 51: 468-474, 2008.
  213. Walter SD(*), Franco EL. Use of latent class models to accommodate inter-laboratory variation in assessing genetic polymorphisms associated with disease risk. Biomed Central Genetics 8: 9(1):51, 2008.
  214. Souza PSA, Maciag PC, Ribeiro K, Petzl-Erler ML, Franco EL, Villa LL(*). Interaction between polymorphisms of the Human Leukocyte Antigen and HPV-16 variants on the risk of invasive cervical cancer. Biomed Central Cancer .8: 246, 2008.
  215. Gohy L, Gorska I, Rouleau D, Ghattas G, Pokomandy A, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Kornegay JR, Franco EL, HIPVIRG Study Group, Coutlée F(*). Genotyping of human papillomavirus dna in anal biopsies and anal swabs collected from hiv-seropositive men with anal dysplasia. Journal of Acquired Immunodeficiency Syndrome 49:32-39, 2008.
  216. Rogoza RM, Ferko N, Bentley J, Meijer C, Berkhof J, Wang KL, Downs L, Smith JS, Franco EL. Optimization of primary and secondary cervical cancer prevention strategies in an era of cervical cancer vaccination: A multi-regional health economic analysis. Vaccine 26S: F46-F58, 2008.
  217. Franco EL, Tsu V, Herrero R, Lazcano E, Hildesheim A, Muñoz N, Murillo R, Sanchez G, Andrus JK. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean. Vaccine 26S: L88-L95, 2008.
  218. Muñoz N, Franco EL, Herrero R, Andrus JK, Quadros C, Goldie S, Bosch FX. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine 26S: L96-L107, 2008.
  219. Hamlin-Douglas LK, Coutlée F, Roger M, Franco EL, Brassard P. Prevalence and Age-Distribution of Human Papillomavirus (HPV) Infection in a Population of Inuit Women in Nunavik, Quebec. Cancer Epidemiology, Biomarkers, and Prevention 17: 3141-3149, 2008.
  220. Meijer CJLM(*), Berkhof J, Castle PE, Hesselink A, Franco EL, Ronco G, Arbyn M, Bosch FX, Cuzick J, Dillner J, Heideman DAM, Snijders PJF. Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older. International Journal of Cancer 124: 516-520, 2009.
  221. Trottier H(§), Mahmud SM, Lindsay L, Jenkins D, Quint W, Wieting SL, Schuind A, Franco EL(*), for the GSK HPV-001 Vaccine Study Group. Persistence of an incident human papillomavirus infection and timing of cervical lesions in previously unexposed young women. Cancer Epidemiology, Biomarkers, and Prevention 18: 854-862, 2009.
  222. De Pokomandy A(§), Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Franco EL, Coutlée F(*), for the HIPVIRG Study Group. Prevalence, clearance and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG Cohort Study. Journal of Infectious Diseases 199: 965-973, 2009.
  223. Coutlée F(*), Trottier H, Simon G, Koushik A, Richardson H, Roger M, Ferenczy A, Franco EL. Low-risk human papillomavirus type 6 DNA load and integration in cervical samples from women with squamous intraepithelial lesions. Journal of Clinical Virology 45: 96-99, 2009.
  224. Coutlée F(*), Mayrand MH, Roger M, Franco EL. Detection and typing of Human Papillomavirus nucleic acids in biological fluids. Public Health Genomics 12:308-318, 2009.
  225. Franco EL(*), Coutlée F(*), Ferenczy A. Integrating HPV vaccination in cervical cancer control programmes. Public Health Genomics 12: 352-361, 2009.
  226. Franco EL, Olsen J, Saracci R, Detels R. Epidemiology’s contributions for a Nobel prize recognition. Epidemiology 20: 632-634, 2009.
  227. Rosen NO, Knäuper B, Pagé G, DiDio P, Morrison E, Mayrand MH, Franco EL, Rosberger Z(*). Uncertainty-inducing and Reassuring Facts about HPV: A Descriptive Study of French-Canadian Women. Health Care for Women International 30:892-902, 2009.
  228. Franco EL(*), Mahmud SM, Tota J, Ferenczy A, Coutlée F. The expected impact of HPV vaccination on the accuracy of cervical cancer screening: The need for a paradigm change. Archives of Medical Research 40: 478-485, 2009.
  229. Kulasingam S(*), Rajan R, St-Pierre Y, Atwood CV, Myers E, Franco EL. Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysis. BMC Medicine 7:69, 2009 (doi:10.1186/1741-7015-7-69).
  230. Rosen NO, Knäuper B, DiDio P, Morrison E, Tabing R, Feldstein A, Amsel R, Mayrand MH, Franco EL, Rosberger Z(*). The impact of intolerance of uncertainty on anxiety after receiving an informational intervention about HPV: A randomized controlled study. Psychology and Health 25: 651-668, 2010.
  231. Burchell AN(§), Tellier PP, Hanley J, Coutlée F, Franco EL(*). Human papillomavirus infections among couples in new sexual relationships. Epidemiology 21(1):31-7, 2010.
  232. Tomita LY(§), Longatto A, Costa MC, Andreoli MAA, Villa LL, Franco EL, Cardoso MA(*). Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women. International Journal of Cancer 126(3): 703-714, 2010.
  233. Burchell AN(§), Tellier PP, Hanley J, Coutlée F, Franco EL(*). Influence of partner’s infection status on prevalent human papillomavirus among persons with a new sex partner. Sexually Transmitted Diseases 37: 34-40, 2010.
  234. Franco EL, Tota J. Human papillomavirus infection and risk of cervical precancer: Using the right methods to answer the right questions. American Journal of Epidemiology 171: 164-168, 2010.
  235. Dang-Tan T(§), Trottier H, Mery LS, Morrison HI, Barr RD, Greenberg ML, Franco EL(*). Determinants of Delays in Treatment Initiation in Children and Adolescents Diagnosed with Leukemia or Lymphoma in Canada. International Journal of Cancer 126: 1936-1943, 2010.
  236. Ramanakumar VA(§), Thomann P, Candeias JM, Ferreira S, Villa LL, Franco EL(*). Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for human papillomavirus infection. Journal of Clinical Microbiology 48: 791-796, 2010.
  237. Ogilvie GS(*), van Niekerk D, Krajden M, Martin RE, Ehlen TG, Ceballos K, Peacock S, Smith L, Kan L, Cook DA, Mei W, Stuart GCE, Franco EL, Coldman AJ. A Randomized Controlled Trial of Human Papilloma Virus (HPV) Testing For Cervical Cancer Screening: Trial Design and Preliminary Results (HPV FOCAL Trial). Biomed Central Cancer 10(1):111, 2010.
  238. Hamlin-Douglas LK, Coutlée F, Roger M, Hanley J, Franco EL, Brassard P(*). Determinants of human papillomavirus infection among Inuit women of Northern Quebec, Canada. Sexually Transmitted Diseases 37: 377-381, 2010.
  239. Cornut G, Gagnon S, Hankins C, Money D, Pourreaux K, , Franco EL, Coutlée F(*), for the Canadian Women’s HIV Study Group. Polymorphism of the capsid L1 gene of human papillomavirus types 31, 33 and 35. Journal of Medical Virology 82: 1168-1178, 2010.
  240. Huh W(*), Einstein MH, Herzog TJ, Franco EL. What is the Role of HPV Typing in the United States Now and in the Next Five Years in a Vaccinated Population? Gynecologic Oncology 117: 481-485, 2010.
  241. Rabachini T, Trottier H, Franco EL, Villa LL(*). Validation of dot blot hybridization and denaturating high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies. Biomed Central Genetics 11:44, 2010.
  242. Mahmud SM(*), Franco EL, Aprikian AG. Use of Non-steroidal anti-inflammatory drugs and prostate cancer risk: A meta-analysis. International Journal of Cancer 127: 1680-1691, 2010.
  243. Siegel EM, Salemi JL, Craft NE, Villa LL, Ferenczy A, Franco EL, Giuliano AR(*). No association between endogenous retinoic acid and human papillomavirus clearance or incident cervical lesions in Brazilian women. Cancer Prevention Research 3: 1007-1014, 2010.
  244. Siegel EM, Salemi JL, Villa LL, Ferenczy A, Franco EL, Giuliano A(*). Dietary consumption of antioxidant nutrients and risk of incident cervical intraepithelial neoplasia. Gynecologic Oncology 118: 289-294, 2010.
  245. Tota J(§), Mahmud SM, Ferenczy A, Coutlée F, Franco EL(*). Promising strategies for cervical cancer screening in the post-HPV vaccination era. Sexual Health 7: 376-382, 2010.
  246. Alvarez J, de Pokomandy A, Rouleau D, Ghattas G, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Franco EL, Coutlée F(*).Episomal and integrated Human papillomavirus type 16 loads and anal intraepithelial neoplasia in HIV-seropositive men. AIDS 24: 2355-2363, 2010.
  247. Perri T(§), Rahimi Kurosh, Ramanakumar AV, Wou K, Pilavdzic D, Franco EL, Gotlieb WH, Ferenczy A(*). Are endometrial polyps true cancer precursors? American Journal of Obstetrics and Gynecology 203: 232e1-e6, 2010.
  248. Trottier H(§), Ferreira S, Thomann P, Costa MC,  Sobrinho JS, Prado JCM, Rohan TE, Villa LL, Franco EL(*). HPV infection and re-infection in adult women: the role of sexual activity and natural immunity. Cancer Research 70: 8569–8577, 2010.
  249. Mayrand MH(*), Franco EL. Integrating novel primary and secondary prevention strategies: The next challenge for cervical cancer control. Future Oncology 6: 1725-1733, 2010.
  250. Ramanakumar AV(§), Goncalves O, Richardson H, Tellier P, Ferenczy A, Coutlée F, Franco EL(*). Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infectious Diseases 10: 326, 2010.
  251. Dufresne S, Sauthier P, Mayrand MH, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL, Coutlée F(*). Human Papillomavirus (HPV) DNA triage of women with Atypical Squamous Cells of Undetermined Significance (ASCUS) with AMPLICOR HPV and Hybrid Capture 2 Assays for the Detection of High-grade Lesions of the Uterine Cervix. Journal of Clinical Microbiology 49: 48-53, 2011.
  252. Cerigo H, MacDonald ME, Franco EL, Brassard P(*). Awareness and knowledge about human papillomavirus among Inuit women in Nunavik, Quebec. Journal of Community Health 36: 56-62, 2011.
  253. Mahmud SM(*§), Franco EL, Turner D, Platt RW, Beck P, Skarsgard D, Tonita J, Sharpe C, Aprikian AG. Use of Non-Steroidal Anti-Inflammatory Drugs and Prostate Cancer Risk: A population-based nested case-control study. Public Library of Science – One 6(1):e16412, 2011.
  254. Tomita LY(§), Roteli-Martins CM, Villa LL, Franco EL, Cardoso MA(*), for the BRINCA Study Team. Associations of dietary dark green and  deep yellow vegetables and fruits with cervical intraepithelial  neoplasia: modification by smoking. British Journal of Nutrition 105: 928-937, 2011.
  255. Ferguson R(§), Ramanakumar AV, Richardson H, Tellier PP, Coutlée F, Franco EL, Roger M(*).Human leukocyte antigen (HLA)-E and HLA-G polymorphisms in human papillomavirus infection susceptibility and persistence. Human Immunology 72(4):337-341, 2011.
  256. de Pokomandy A(§), Rouleau D, Ghattas G, Trottier H, Vézina S, Coté P, Macleod J, Allaire G, Hadjeres R, Franco EL, Coutlée F(*). HAART and Progression to High-Grade Anal Intraepithelial Neoplasia in Men Who Have Sex with Men and Are Infected with HIV. Clinical Infectious Diseases 52:1174-1181, 2011.
  257. Sénécal M(*), Brisson M, Maunsell E, Ferenczy A, Franco EL, Ratnam S, Coutlée F, Palefsky JM, Mansi JA. Loss of quality of life associated with genital warts: baseline analyses from a prospective study. Sexually Transmitted Infection 87:209-215, 2011.
  258. Coutlée F(*), Ratnam S, Ramanakumar AV, Insinga RR, Bentley J, Escott N, Ghatage P, Koushik A, Ferenczy A, Franco EL. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada. Journal of Medical Virology 83:1034-1041, 2011.
  259. Brisson M(*), Van De Velde N, Franco EL, Drolet M, Boily MC. Incremental impact of adding boys to current hpv vaccination programmes: role of herd immunty. Journal of Infectious Diseases 204(3): 372-376, 2011.
  260. Vanni T(§*), Legood R, Franco EL, Villa LL, Luz PM, Schwartsmann G. Economic evaluation of strategies for managing women with equivocal cytological results in Brazil. International Journal of Cancer 129(3): 671-679, 2011.
  261. Sangwa-Lugoma G(§), Ramanakumar AV, Mahmud S, Liaras J, Kayembe PK, Tozin RR, Lorincz A, Franco EL(*). Prevalence and determinants of high-risk human papillomavirus infection in women from a sub-Saharan African community. Sexually Transmitted Diseases 38(4): 308-315, 2011.
  262. Drolet M, Brisson M(*), Maunsell E, Franco EL, Coutlée F, Ferenczy A, Ratnam S, Fisher W, Mansi J. The impact of anogenital warts on health-related quality of life: a 6-month prospective study. Sexually Transmitted Diseases 38: 949-956, 2011.
  263. Tota JE(§), Chevarie-Davis M, Richardson LA, deVries M, Franco EL(*). Epidemiology and burden of HPV infection and related diseases: Implications for prevention strategies. Preventive Medicine 53 (Suppl 1): S12-21, 2011.
  264. Burchell AN(§*), Coutlée F, Tellier PP, Hanley J, Franco EL. Genital transmission of human papillomavirus in recently-formed, heterosexual couples. Journal of Infectious Diseases 204(11):1723-1729, 2011.
  265. Legault V, Burchell A, Goggin P, Nicolau B, Forest P, Mayrand MH, Franco EL, Coutlée F(*). Generic Microtiter Plate Assay for Triaging Clinical Specimens prior to Genotyping of HPV DNA via Consensus PCR. Journal of Clinical Microbiology 49: 3977-3979, 2011.
  266. Richardson LA(§), Tota J, Franco EL(*). Optimizing Technology for Cervical Cancer Screening in High-Resource Settings. Expert Review of Obstetrics & Gynecology 6: 343-353, 2011.
  267. Mahmud SM(§*), Sangwa-Lugoma G, Nasr SH, Liaras J, Kayembe PK, Tozin RR, Drouin P, Lorincz A, Ferenczy A, Franco EL. Comparison of Human Papillomavirus Testing and Cytology for Cervical Cancer Screening in a Primary Health Care Setting in the Democratic Republic of the Congo. Gynecologic Oncology 124: 286-291, 2012.
  268. Lapierre SG, Sauthier P, Mayrand MH, Dufresne S, Petignat P, Provencher D, Drouin P, Gauthier P, Dupuis MJ, Michon B, Ouellet S, Hadjeres R, Ferenczy A, Franco EL,  Coutlée F(*). Human Papillomavirus (HPV) DNA Triage of Women with Atypical Squamous Cells of Undetermined Significance (ASC-US) with Cobas 4800 HPV and Hybrid Capture 2 Tests for Detection of High-Grade Lesions of the Uterine Cervix. Journal of Clinical Microbiology 50:1240-1244, 2012.
  269. Cerigo H, Coutlée F, Franco EL, Brassard P(*). Dry self-sampling versus provider-sampling of cervicovaginal specimens for human papillomavirus detection in the Inuit population of Nunavik, Quebec. Journal of Medical Screening 19: 42-48, 2012.
  270. Lau S(§), Vaknin Z, Ramana-Kumar AV, Halliday D, Franco EL, Gotlieb WH(*).Outcomes and Cost Comparisons After Introducing a Robotics Program for Endometrial Cancer Surgery. Obstetrics & Gynecology 119: 717-724, 2012.
  271. Toporowski A, Harper S, Fuhrer R, Buffler PA, Detels R, Krieger N, Franco EL(*). Burden of Disease, Health Indicators, and Challenges for Epidemiology in North America. International Journal of Epidemiology 41: 540-556, 2012.
  272. Cerigo H, Macdonald ME, Franco EL, Brassard P(*). HPV Detection by Self-Sampling in Nunavik, Quebec: Inuit Women’s Sampling Method Preferences. Journal of Aboriginal Health 8: 29-39, 2012.
  273. Siegel EM(*), Patel N, Lu B, Lee JH, Nyitray AG, Huang X, Villa LL, Franco EL, Giuliano AR. Circulating Biomarkers of Iron Storage and Clearance of Incident Human Papillomavirus Infection. Cancer Epidemiology, Biomarkers and Prevention 21: 859-865, 2012.
  274. Siegel E, Patel N, Lu B, Lee JH, Nyitray AG, Craft NE, Frenkel K, Villa LL, Franco EL, Giuliano AR(*). Biomarkers of oxidant load and type-specific clearance of prevalent oncogenic human papillomavirus infection: Markers of immune response? International Journal of Cancer 131: 219-228, 2012.
  275. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam S, Cain J, Garcia FAR, Moriarty A, Waxman A, Wilbur D, Wentzensen N, Downs L, Spitzer M, Moscicki AB, Saraiya M, Franco EL, Stoler MH, Schiffman M, Castle PE(*), Myers ER(*). American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. This article was jointly published in CA Cancer Journal for Clinicians 62: 147-172, 2012; American Journal of Clinical Pathology 137-516-542, 2012, and Journal of Lower Genital Tract Disease 16: 175-204, 2012.
  276. Cerigo H, Macdonald ME, Franco EL, Brassard P(*). Inuit Women’s Attitudes and Experiences towards Cervical Cancer and Prevention Strategies in Nunavik, Quebec. International Journal of Circumpolar Health 71: 17996, 2012 .
  277. Ferguson R(§), Ramanakumar AV, Koushik A, Coutlée F, Franco EL, Roger M(*), for the Biomarkers of Cervical Cancer Risk (BCCR) Study Team. Human leukocyte antigen G polymorphism is associated with an increased risk of invasive cancer of the uterine cervix. International Journal of Cancer 131: E312-E319, 2012.
  278. Ribeiro R(§*), Monteiro C, Azevedo A,  Cunha V,  Ramanakumar AV,  Fraga AM,  Pina FM, Lopes CMS, Medeiros R,  Franco EL. Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction. PLoS One 7(6): e39236, 2012.
  279. Malagon T, Drolet M, Boily MC, Franco EL, Jit M, Brisson J, Brisson M(*). Cross-protective efficacy of two human papillomavirus vaccines : A systematic review and meta-analysis. Lancet Infectious Diseases 12:781-789, 2012.
  280. Drolet M, Brisson M(*), Maunsell E, Franco EL, Coutlée F, Ferenczy A, Fisher W, Mansi J. The psychosocial impact of an abnormal cervical smear result. Psycho-Oncology 21: 1071-1081, 2012.
  281. Landry ME, Salit IE, Rodrigues-Coutlée C, Money D, Rebbapragada A, Tinmouth J, Hankins C, Gorska-Flipot I, Archambault J, Franco EL, Coutlée F(*). Ano-genital Infection by Human papillomavirus type 97 in Canadian men and women at risk of or infected with the Human Immunodeficiency Virus. Virology Journal 9: 243, 2012 doi:10.1186/1743-422X-9-243.
  282. Van de Velde N, Boily MC, Drolet M, Franco EL, Mayrand MH, Kliewer EV, Coutlée F, Laprise JF, Malagon T, Brisson M(*). Population-level impact of the bivalent, quadrivalent and nonavalent HPV vaccines: a model-based analysis. Journal of the National Cancer Institute 104: 1712-1723, 2012.
  283. Franco EL, Sanjose S, Broker TR, Stanley MA, Chevarie-Davis M, Isidean SD, Schiffman M. Human papillomavirus and cancer prevention: Gaps in knowledge and prospects for research, policy, and advocacy. Vaccine 30 (Suppl 5): F175-182, 2012.
  284. Franco EL. Towards More Eclectic Evidence-based Medicine in Cancer Prevention and Control. Preventive Medicine 55: 552-553, 2012.
  285. Ogilvie GS, Krajden M, vanNiekerk DJ, Martin RE, Ehlen TG, Ceballos K, Smith LW, Kan L, Cook DA, Stuart GC, Franco EL, Coldman AJ. Primary cervical cancer screening with HPV testing compared to liquid based cytology: Results of round 1 of a randomized controlled trial – the HPV FOCAL Study. British Journal of Cancer 107: 1917-1924, 2012.
  286. Coutlée F(*), de Pokomandy A. Franco EL. Epidemiology, natural history and risk factors for anal intraepithelial neoplasia. Sexual Health 9: 547-555, 2012.
  287. Chevarie-Davis M(§), Ramanakumar AV, Ferreira S, Ferenczy A, Villa LL, Franco EL(*), for the Ludwig-McGill Cohort Study. Assessment of the performance of algorithms for cervical cancer screening: Evidence from the Ludwig-McGill Cohort Study. Gynecologic Oncology 128: 415-419, 2013.
  288. Formentin A, Archambault J, Koushik A, Richardson H, Brassard P, Franco EL, Coutlee F(*). Human papillomavirus type 52 polymorphism and high-grade lesions of the uterine cervix. International Journal of Cancer 132: 1821-1830, 2013.
  289. Walter SD(*), Riddell CA, Rabachini T, Villa LL, Franco EL. Accuracy of p53 codon 72 polymorphism status determined by multiple laboratory methods: a latent class model analysis. PLoS-One 8(2):e56430.
  290. Tota JE(§), Ramanakumar AV, Mahmud SM., Trevisan A, Villa LL, Franco EL(*), for the Ludwig-McGill Cohort Study Group. Cervical Human Papillomavirus Detection is Not Affected by Menstrual Phase. Sexually Transmitted Infections 89: 202-206, 2013.
  291. Andalib A(§), Ramana-Kumar AV, Bartlett G, Franco EL, Ferri LE(*). Influence of postoperative infectious complications on long-term survival of lung cancer patients: a population-based cohort study. Journal of Thoracic Oncology 8: 554-561, 2013.
  292. Cerigo H, Coutlee F, Franco EL, Brassard P(*). Factors associated with cervical cancer screening uptake among Inuit women in Nunavik, Quebec, Canada. Biomed Central Public Health, 13:438, 2013.
  293. Rositch AF(*), Koshiol J, Hudgens MG, Razzaghi H, Backes DM, Pimenta JM, Franco EL, Poole C, Smith JS. Patterns of persistent genital human papillomavirus infection among women worldwide: A literature review and meta-analysis. International Journal of Cancer 133: 1271-1285, 2013.
  294. Drolet M, Boily MC, Van de Velde N, Franco EL, Brisson M(*). Vaccinating girls and boys with different human papillomavirus vaccines: Can it optimise population-level effectiveness? PLoS-One 8(6):e67072.
  295. Trevisan A(§*), Schlecht NF, Ramanakumar AV, Villa LL, Franco EL, Ludwig-McGill Study Group. HPV16 viral load measurement as a predictor of infection clearance. Journal of General Virology 94: 1850-1857, 2013.
  296. Oliveira LB, Louvanto K, Ramanakumar AV, Franco EL, Villa LL(*), for the Ludwig-McGill Cohort Study. Polymorphism in the promoter region of the Toll-Like Receptor 9 gene and cervical human papillomavirus infection. Journal of General Virology 94: 1858-1864. 2013.
  297. Metcalfe S, Roger M,Faucher MC, Coutlée F, Franco EL, Brassard P(*). The frequency of HLA alleles in a population of Inuit women of northern Quebec. International Journal of Circumpolar Health 72: 21350, 2013. DOI: 10.3402/ijch.v72i0.21350 .
  298. Tota J(§), Ramana-Kumar AV, Jiang M, Dillner J, Walter SD, Kaufman JS, Coutlée F, Villa LL, Franco EL(*). Epidemiological Approach to Evaluate the Potential for Human Papillomavirus Type Replacement Post-vaccination. American Journal of Epidemiology 178: 625-634, 2013.
  299. Brisson M(*), Laprise JF, Drolet M, Van de Velde N, Franco EL, Kliewer EV, Ogilvie G, Deeks SL, Boily MC. Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: A transmission-dynamic modeling study. Vaccine  31: 3863-3871, 2013.
  300. Isidean SD(§), Franco EL(*). Counterpoint: Cervical Cancer Screening Guidelines: Approaching the Golden Age. American Journal of Epidemiology (in press).
  301. Ogilvie GS(*), Smith LW, van Niekerk DJ, Khurshed F, Krajden M, Saraiya M, Goel V, Rimer B BK, Greene SB, Hobbs S, Coldman AJ, Franco EL. Women's intentions to receive cervical cancer screening with primary human papillomavirus testing. International Journal of Cancer (in press).
  302. Metcalfe S, Roger M, Faucher MC, Coutlée F, Franco EL, Brassard P(*). The association between human leukocyte antigen (HLA)-G polymorphisms and human papillomavirus (HPV) infection in Inuit women of northern Quebec. Human Immunology (in press).
  303. Tomita LY, D' Almeida V, Villa LL, Franco EL, Cardoso MA(*), for the BRINCA Study Group. Polymorphisms in genes involved in folate metabolism modify the association of dietary and circulating folate and vitamin B-6 with cervical neoplasia. Journal of Nutrition (in press).

PUBLICATIONS (peer-reviewed articles, authorship as part of study group)

  1. Saslow D, Runowicz CD, Solomon D, Moscicki AB, Smith RA, Eyre HJ, Cohen C; American Cancer Society Advisory Groups. American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer Journal for Clinicians 52: 342-362, 2002.
  2. Herrero R, Castellsague X, Pawlita M, Lissowska J, Kee F, Balaram P, Rajkumar T, Sridhar H, Rose B, Pintos J, Fernandez L, Idris A, Sanchez MJ, Nieto A, Talamini R, Tavani A, Bosch FX, Reidel U, Snijders PJ, Meijer CJ, Viscidi R, Munoz N, Franceschi S; IARC Multicenter Oral Cancer Study Group. Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. Journal of the National Cancer Institute 95: 1772-1783, 2003.
  3. Tomita LY, Almeida LC, Roteli-Martins C, D'Almeida V, Cardoso MA; BRINCA Study Team. Dietary predictors of serum total carotene in low-income women living in São Paulo, southeast Brazil. Public Health Nutrition 12: 2133-2142, 2009.
  4. Luciani S, Vardy L, Paci E, Adewole I, Sasco A, Calvacante T; ICCC-3 Session C Group. Cancer prevention and population-based screening. Tumori 95: 597-609, 2009.

PUBLICATIONS (invited editorials, non-peer-reviewed articles, letters, etc.)

  1. Franco EL, Simons AR. Linear-exponential curve fitting in biology. PPC Calculator Journal 9: 14-16, 1982.
  2. Camargo B(*§), Saba L, Franco E. Tumor de Wilms no Brasil. Oncologia Atual 1: 6-8, 1991.
  3. Franco EL. Pautas para el tratamiento del tumor de Wilms: Invited commentary: The importance of cooperative groups in oncology. Salud y Ciencia 2: 16, 1992.
  4. Franco EL. Race and gender influences on the survival of patients with mouth cancer. Invited commentary. Oncology Digest 2: 25-26, 1994.
  5. Camargo B(§), Franco E. Report on the First South American Wilms' Tumor Workshop. SIOP News 9: 9, 1994.
  6. Franco EL. Invited Editorial: A personal view of the epidemiological presentations in the 13th International Papillomavirus Conference, Amsterdam. Papillomavirus Report 5: 183-187, 1994.
  7. Franco EL. Recent advances in the molecular epidemiology of cervical cancer. Sao Paulo Medical Journal 113 (2, suppl.): 28-29, 1995.
  8. Franco EL. Invited Editorial: A personal view of the epidemiological presentations in the 14th International Papillomavirus Conference, Quebec City. Papillomavirus Report 6: 147-150, 1995.
  9. Franco EL(*), Syrjänen K, De Wolf C, Patnick J, Ferenczy A, McGoogan E, Bosch X, Singer A, Muñoz N, Meheus A, Monsonego J. Meeting report: New developments in cervical cancer screening and prevention. Cancer Epidemiology, Biomarkers & Prevention 5: 853-856, 1996.
  10. Latorre MR(§), Franco EL. Epidemiologia dos tumores na infância. Acta Oncologica Brasileira 16: 201-219, 1996.
  11. Franco EL. Invited editorial: Understanding the epidemiology of genital infection with oncogenic and non-oncogenic human papillomaviruses: A promising lead for primary prevention of cervical cancer. Cancer Epidemiology, Biomarkers & Prevention 6: 759-761, 1997.
  12. Franco EL. Invited editorial: Defining safe drinking water. Epidemiology 8: 607-609, 1997. Reprinted in Infectious Diseases in Clinical Practice 7: 63-65, 1998.
  13. Richardson H(§), Franco EL(*). Human Papillomavirus infection and cervical cancer: an update. Mature Medicine Canada 1: 26-28, 1998.
  14. Franco EL. Invited editorial: “A epidemiologia do câncer no Brasil: onde estamos e para onde devemos ir.” Revista da Sociedade Brasileira de Cancerologia 1: 10-13, 1998.
  15. Bruneau J(*§), Lamothe F, Franco E. Letter to the Editor: Re: High rates of HIV infection among injection drug users. American Journal of Epidemiology 148: 716-717, 1998.
  16. Latorre MR(§), Franco EL. Epidemiologia dos sarcomas. Acta Oncologica Brasileira 18: 3-14, 1998.
  17. Franco EL. Invited editorial: “Ponto de vista: A epidemiologia do câncer no Brasil.” Revista Médicos 2: 96-100, 1999.
  18. Franco EL. Invited Letter to the Editor: Being a medical scientist: it takes love and dedication to research, not a title. McGill Journal of Medicine 5: 2-3, 1999.
  19. Bruneau J(*§), Franco E. Letter to the Editor: Re: High rates of HIV-1 infection among drug users participating in needle exchange programs in Montreal. American Journal of Epidemiology 150: 326, 1999.
  20. Franco EL, Schlecht NF. Authors’ response to “Invited Commentary: More evidence of increased risks of cancer among alcohol drinkers. American Journal of Epidemiology 150: 1141, 1999.
  21. Schlecht NF(§), Franco EL(*). Letter to the Editor: Authors’ response to “Re: Interaction between tobacco and alcohol and the risk of cancers of the upper aero-digestive tract in Brazil.” American Journal of Epidemiology 152: 193-194, 2000.
  22. Sharpe CR(§), Franco EL(*). Letter to the Editor: Re: The influence of parental age on the risk of Wilms’ tumour. Paediatric and Perinatal Epidemiology 14: 284-285, 2000.
  23. Bosch FX, Muñoz N, Sanjosé S, Franco EL, Lowy DR, Schiffman M, Franceschi S, Kjær S, Meijer CJLM, Frazer IH, Cuzick J. Letter to the editor Re:. Cervical carcinoma and human papillomavirus: on the road to preventing a major human cancer. Journal of the National Cancer Institute 93: 1349-1350, 2001.
  24. Franco EL, Duarte-Franco E, Ferenczy A. Reply to E Ellison: Re: The merits of new alternatives to the Papanicolaou test. Canadian Medical Association Journal 165:739-40, 2001.
  25. Duarte-Franco E, Franco EL(*). Determinants of patient survival in cervical cancer: an overview. CME Journal of Gynecologic Oncology 6: 173-183, 2001.
  26. Mayrand MH(§), Franco EL(*). Screening elderly women for urogenital cancers: When should we stop giving older women Pap tests? Geriatrics & Aging 5: 39-42, 2002.
  27. Villa LL, Amestoy G, Franco E. Introduction. Virus Research 189: 161, 2002.
  28. Villa LL, Bernard HU, Kast M, Hildesheim A, Amestoy G, Franco E. Past, present, and future of HPV research: highlights from the 19th International Papillomavirus Conference-HPV 2001. Virus Research 189: 163-173, 2002.
  29. Gilbert L, Krishnamurthy S, Tan SL, Franco EL. Letter to the Editor Re: Estrogen replacement therapy and risk of ovarian cancer in post-menopausal women. Journal of the American Medical Association 288: 2538-2539, 2002.
  30. Wolf JK, Franco EL, Arbeit JM, Shroyer KR, Wu TC, Runowicz CD, Tortolero-Luna G, Herrero R, Crum CP. Innovations in understanding the biology of cervical cancer. Cancer 98 (Suppl): 2064-2069, 2003.
  31. Franco EL. Invited Commentary: Are we ready for a paradigm change in cervical cancer screening? Lancet 362: 1866-1867, 2003.
  32. Franco EL, Duarte-Franco E, Ferenczy A. Prospects for controlling cervical cancer at the turn of the century. Salud Publica de Mexico 45 (suppl. 3): S367-375, 2003.
  33. Franco EL. Invited Editorial: Male circumcision and AIDS in Africa: Primum non nocere versus the collective good. Epidemiology 15: 133-134, 2004.
  34. Franco EL. Invited Editorial: Randomized controlled trials of hpv testing and Pap cytology: Toward evidence-based cervical cancer prevention. International Journal of Cancer 110: 1-2, 2004.
  35. Mahmud S(§), Franco EL(*). Invited Editorial: An overview of epidemiologic and public health research on HPVs presented at the 21st International Papillomavirus Conference in Mexico City. Papillomavirus Report 15: 121-123, 2004.
  36. Franco EL, Duarte-Franco EF. Invited Commentary: Screening every three years, instead of annually, would result in a small increase in risk of cervical cancer (Sawaya et al., N Engl J Med 2003; 349:1501-1509). Evidence-Based Obstetrics & Gynecology 6: 204-205, 2004.
  37. Lau S(§), Franco EL(*). Management of low-grade cervical lesions in young women. Canadian Medical Association Journal 173: 771-774, 2005.
  38. Franco EL. Invited Commentary: Epidemiology as a tool to reveal inequalities in breast cancer care. Public Library of Science-Medicine 3(3): e48, 2006.
  39. Franco EL, Lau S. LSIL in young women: Inaction is not an option. Canadian Medical Association Journal 174: 813, 2006.
  40. Franco EL(*), Ferenczy A. Invited Commentary: Is human papillomavirus testing with cytological triage a more logical approach in cervical cancer screening? Lancet Oncology 7: 527-529, 2006.
  41. Franco EL, Mayrand MH, Trottier H. Cervical cancer prevention: Promises and perils in a changing landscape. Oncology Exchange 5: 9-13, 2006.
  42. Franco EL, Trottier H. Invited Editorial: A new window into the natural history of human papillomavirus infection: A view from the ALTS (Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study) trial. Journal of Infectious Diseases 195: 1560-1562, 2007.
  43. Sichero L, Trottier H, Ferreira S, Duarte-Franco E, Franco EL, Villa LL(*). Re: Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. Journal of the National Cancer Institute 99: 653-654, 2007.
  44. Franco EL. Invited Commentary: Which is the more useful screening tool for cervical cancer, HPV or Pap? Parkhurst Exchange 15: 123-125, 2007
  45. Ferenczy A(*), Franco EL. HPV: Answering your worried patients' questions. Contemp OB/GYN 52:48-54, 2007.
  46. Franco EL. Invited commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted. British Medical Journal 335: 378-379, 2007.
  47. Petignat P(*), Franco EL, Coutlée F. Letter: Response to Pretorius and Belinson. Gynecologic Oncology 107: 596-597, 2007.
  48. Kim JJ(*), Franco EL, Stout NK, Goldie SJ. Letter: The authors reply re: Multi-Parameter Calibration of a Natural History Model of Cervical Cancer. American Journal of Epidemiology 166: 983-984, 2007.
  49. Franco EL, de Pokomandy A, Spence AR, Burchell AN, Trottier H, Mayrand MH, Lau S. Letter: Vaccination against human papillomavirus. Canadian Medical Association Journal 177: 1524-1525, 2007.
  50. Franco EL. Expected Impact of HPV Vaccination on Cervical Cancer Screening Practices: Time to Rethink Preventive Strategies. African Organisation for Research and Training In Cancer (AORTIC) Newsletter 9: 15-16, 2007.
  51. Brogly SB(*), Franco EL, Watts DH, Van Dyke R. Letter: Reproductive health of adolescent girls perinatally infected with HIV. American Journal of Public Health 97: 1930, 2007.
  52. Gorska-Flipot I, Sawicki J, Gaboury LA, Krajinovic M, Labuda D, Brukner I, Rouleau D, Ghattas G, Franco EL, Coutlée F. Newly isolated HPV-97 related to HPV-18 and 45 is highly prevalent in HIV positive males from the Montreal area. International Journal of Cancer 122: 1195-1197, 2008.
  53. Franco EL, Duarte-Franco E. Invited Commentary: Ovarian cancer and oral contraceptives. Lancet 371: 277-278, 2008.
  54. Franco EL, Trottier H. Invited Editorial: Reassessing the epidemiology of human papillomavirus infection: Back to basics. Sexually Transmitted Diseases 35: 283-285, 2008.
  55. Franco EL, Mayrand MH, Ratnam S. Letter: Human Papillomavirus DNA versus Papanicolaou Screening Tests for Cervical Cancer. New England Journal of Medicine 358: 643, 2008.
  56. Franco EL, Spence AR. Invited Commentary: Smoking and human papillomavirus infection: the pursuit of credibility for an epidemiologic association. International Journal of Epidemiology 37: 547-548, 2008.
  57. Franco EL, Paavonen J. Foreword: Human papillomavirus vaccination and screening as the new paradigm in cervical cancer prevention. Therapy 5: 261-263, 2008.
  58. Franco EL, Drummond M. Foreword: Cost-effectiveness Analysis: An Essential Tool to Inform Public Health Policy in Cervical Cancer Prevention. Vaccine 26S: F1-F2, 2008.
  59. Bosch FX; Editors (Bosch FX, Stanley M, Wright TC, Franco EL, Herrero R, Munoz N, Cuzick J, Garland SM). A scientific response to prevent cervical cancer in the world. Vaccine 26 Suppl 10: v-vi, 2008.
  60. Bosch FX; Editors (Franco EL, Herrero R, Munoz N, Cuzick J, Garland SM, Bosch FX, Stanley M, Wright TC). A scientific response to prevent cervical cancer in the world. Vaccine 26 Suppl 11: v-vi, 2008.
  61. Franco EL, Coutlée F. Invited Editorial: Prognostic value of measuring load of human papillomavirus DNA in cervical samples: an elusive target. Journal of the National Cancer Institute 101:131-133, 2009.
  62. Franco EL. Invited Commentary: Is the UK ready to embrace HPV testing? Lancet Oncology 10: 643-644, 2009.
  63. Franco EL. Invited Editorial: Managing low grade and borderline cervical abnormalities: The dilemma of choosing between conservative and aggressive policies remains. British Medical Journal 339: b3014, 305-306, 2009.
  64. Franco EL, Wallace S. Foreword: How multidisciplinary research advanced the mission of cervical cancer prevention. Public Health Genomics 12: 264-267, 2009.
  65. Franco EL. Invited Editorial: A new generation of studies of human papillomavirus DNA testing in cervical cancer screening. Journal of the National Cancer Institute 101: 1600-1601, 2009.
  66. Tota J(§), Franco EL(*). Effectiveness of cervical cancer screening at different ages. Womens Health 5: 613-616, 2009.
  67. Franco EL, Turgeon GA. Invited Editorial: Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: Raising the Bar. Public Library of Science – Medicine 7(9): e1000338, 2010. doi:10.1371/journal.pmed.1000338.
  68. Franco EL. Invited Editorial: Persistent HPV infection and cervical cancer risk: Is the scientific rationale for changing the screening paradigm enough? Journal of The National Cancer Institute 102: 1451-1453, 2010.
  69. Franco EL. Foreword. Future Medicine, DOI:10.2217/EBO.11.82:2-5, 2011.
  70. Petermann L(*), McLean D, Stuart G, Sherman M, Franco E. Meeting report: National Symposium on Infectious Agents and Cancer. Canadian Journal of Infectious Diseases & Medical Microbiology 22(3):e16, 2011.
  71. Franco EL. Preventive medicine: new editorial office but the same vision. Preventive Medicine 56: 1-2, 2013.
  72. Rosberger Z(*), Perez S, King L, Franco EL. Public perception: A significant challenge in the battle against HPV. Oncology Exchange 12: 16-20, 2013.
  73. Brisson M(*), Drolet M, Boily MC, Malagón T, Franco EL, Laprise J, Van de Velde N, Mayrand MH, Kliewer EV, Coutlée F. Letter re: population-level impact of the bivalent, quadrivalent, and candidate nonavalent human papillomavirus vaccines: a comparative model-based analysis. Journal of the National Cancer Institute 105: 664-665, 2013.
  74. Franco EL, Shinder GA. Combatting obesity - A helping hand from the business community. Preventive Medicine 57: 251-252, 2013.

MANUSCRIPTS SUBMITTED

(*) corresponding author, (§) a student of mine as first author

  1. Ferko N(*), Kohli MA, Buitendyk M, Bosch FX, Standaert BA, Franco EL. Clustering countries according to correlates of cervical cancer risk:  An approach for improving the coverage of health economic models of cervical cancer prevention strategies. (submitted for publication).
  2. Ribeiro R(§), Monteiro C, Ramanakumar A, Guedes A, Francisco N, Ferreira AL, Fraga A, Sousa M, Cunha V, Azevedo A, Maurício J, Lobo F, Pina F, Calais-da-Silva F, Lopes C, Franco EL, Medeiros R(*). Inherited variation in adipokine pathway genes may determine prognosis for prostate cancer patients receiving androgen-deprivation therapy. (submitted for publication).
  3. Dal-Ré R(*), Ioannidis JP, Bracken MB, Buffler PA, Chan AW, Franco EL, La Vecchia C, Weiderpass E. Should prospective registration of observational research be only a matter of willingness? (submitted for publication).
  4. Bosch FX(*), Broker TR, Forman D, Moscicki AB, Gillison ML, Doorbar J, Stern PL, Stanley M, Arbyn M, Poljak M, Cuzick J, Castle PE, Schiller JT, Markowitz LE, Fisher WA, Canfell K, Denny LA, Franco EL, Steben M, Kane MA, Schiffman M, Meijer CJLM, Sankaranarayanan R, Castellsagué X, Kim JJ, Brotons M, Alemany L, Albero G, Diaz M, Sanjosé S, for the authors of the ICO Monograph. Comprehensive Control of Human Papillomavirus Infections and Related Diseases. (submitted for publication).
  5. Isidean SD(§*), Coutlée F, Franco EL. Cobas® 4800 HPV Test, A Real-Time Polymerase Chain Reaction Assay for the Detection of Human Papillomavirus in Cervical Specimens. (submitted for publication).
  6. Tota JE(§*), Ramanakumar AV, El-Khatib Z, Franco EL. The Road Ahead for Cervical Cancer Prevention and Control. (submitted for publication).

BOOKS

  1. Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell Science, Oxford, 1997, 470 pages, ISBN 0-632-04765-8 (personal authorship of individual chapters listed below).
  2. Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002, 430 pages, ISBN 0-387-95188-1 (personal authorship of individual chapters listed below).

JOURNAL SUPPLEMENTS

  1. Villa LL, Amestoy G, Franco E (Guest Editors). Special Issue: 19th International Papillomavirus Conference, Florianopolis, Brazil, 1–7 September 2001. Virus Research 189: 161-314, 2002 (personal authorship of two articles listed above).
  2. Bosch FX, Cuzick J, Schiller J, Garnett G, Meheus A, Franco E, Wright T (Co-Editors). HPV Vaccines and Screening in the Prevention of Cervical Cancer. Vaccine, Volume 24, Supplement 3, 31 August 2006, ISSN 0264-410X (personal authorship of four articles listed above).
  3. Franco EL, Paavonen J (Guest Editors). Special Focus Issue – HPV vaccination. Future Therapy 5(3) May 2008.
  4. Franco EL. (Guest Editor) HPV Today: Special issue on Canada. No. 15, June 2008. Bypass Ediciones, Madrid, Spain.
  5. Bosch FX, Wright T, Ferrer E, Munoz N, Franco EL, Herrero R, Bruni L, Garland S, Cuzick J, Louie K, Stanley M. (Co-Editors). Prevention of Cervical Cancer: Progress and Challenges on Hpv Vaccination and Screening. Vaccine Vol. 26, Supp. 10, 2008, ISSN 0264-410X.
  6. Bosch FX, Munoz N, Herrero R, Bruni L, Garland S, Cuzick J, Louie K, Wright T, Stanley M, Ferrer E, Franco EL. (Co-Editors). Prevention of Cervical Cancer in the Latin American and Caribbean Region. Vaccine Vol. 26, Supp. 11, 2008, ISSN 0264-410X. (personal authorship of two articles listed above).
  7. Bosch FX, Garland S, Louie K, Munoz N, Franco EL, Herrero R, Bruni L, Wright T, Stanley M, Ferrer E, Cuzick J. (Co-Editors). Prevention of Cervical Cancer in the Asia-Pacific Region. Vaccine Vol. 26, Supp. 12, 2008, ISSN 0264-410X.
  8. Franco EL, Drummond MF (Guest Editors). Health economics of HPV vaccination for cervical cancer prevention: Historical developments and practical applications. Vaccine Vol. 26, Supp. 5, 2008.
  9. Franco EL (Guest Editor). Special issue on Cervical Cancer Prevention and HPV Vaccines. Public Health Genomics Vol. 12, No. 5-6, 2009.
  10. Franco EL (Guest Editor). Human Papillomavirus Vaccines. Future Medicine E-Book, Future Science Group, ISBN 978-1-78084-000-0, 2011

BOOK CHAPTERS AND MONOGRAPHS

  1. Mirra AP, Franco EL(*). Cancer Incidence in Sao Paulo, Brazil. In: Franco EL (ed.). LICR Monograph series in Cancer Epidemiology, Vol. 1, Ludwig Institute for Cancer Research, 1985.
  2. Carvalho MRC, Franco EL(*). Cancer Incidence in Recife, Brazil. In: Franco EL (ed.). LICR Monograph Series in Cancer Epidemiology, Vol. 2, Ludwig Institute for Cancer Research, 1986.
  3. Mirra AP, Franco EL(*). Cancer Mortality in Sao Paulo, Brazil. In: Franco EL (ed.). LICR Monograph series in Cancer Epidemiology, Vol. 3, Ludwig Institute for Cancer Research, 1987.
  4. Soto JC(*), Levy M, Allard R, Franco EL. Survey of attitudes, beliefs and knowledge related to AIDS among dental professionals in Quebec. In: Ajdukovic D (Ed.) Oral AIDS: manifestations, safety measures and questions of transmissibility. Elsevier, New York, 1990.
  5. Kowalski LP(§), Franco EL(*). Epidemiologia do câncer no Brasil e no mundo. In: Schwartzmann G (ed.) Oncologia clínica: Princípios e prática. Editora Artes Medicas, Sao Paulo, 1991 (pp. 19-30).
  6. Franco EL. Measurement errors in epidemiologic studies of human papillomavirus and cervical cancer. In: Muñoz N et al. (eds.) The epidemiology of human papillomavirus and cervical cancer. IARC scientific publication no. 119, Oxford University Press, Oxford, 1992 (pp. 181-197).
  7. Franco EL. Rapporteur's summary and discussion: Association of HPV and anogenital cancer and implications for screening policy. In: Muñoz N et al. (eds.) The epidemiology of human papillomavirus and cervical cancer. IARC scientific publication no. 119, Oxford University Press, Oxford, 1992 (pp. 283-284).
  8. Mandeville R, Mercier G, Oth D, Descoteaux JP, Lis M, Franco E, Houde M, Tremblay L. IAF chronic carcinogenicity evaluation of 60 Hz linear sinusoidal continuous wave magnetic fields in rats: Protocol outline and quality assurance program development. In: Blank M (ed.) Electricity and magnetism in biology and medicine. San Francisco Press, San Francisco, 1993 (pp. 419-422).
  9. Franco EL. Epidemiologia do cancer mamario e ginecologico. In: Abrao F (ed.) Tratado de oncologia genital e mamaria. Editora Roca, Sao Paulo, 1995 (pp. 3-16).
  10. Franco EL. Epidemiology of anogenital warts and cancer. In: Reid R, Lorincz A (eds.) Human Papillomaviruses I. Obstetrics and Gynecology Clinics of North America, W.B. Saunders, Philadelphia, 23: 597-623, 1996.
  11. Franco EL. Epidemiology in the study of cancer. In: Bertino JR et al. (eds.), Encyclopedia of Cancer, Vol. 1. Academic Press, San Diego, 1997 (pp. 621-641).
  12. Franco EL, Monsonego J. Introduction. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. xiii-xiv).
  13. Franco EL, Villa LL, Richardson H, Rohan T, Ferenczy A. Epidemiology of cervical human papillomavirus infection. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 14-22).
  14. Franco EL. Statistical issues in studies of human papillomavirus infection and cervical cancer. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 39-50).
  15. Ferenczy A, Franco EL. HPV DNA testing using liquid-based cytology. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 348-353).
  16. Villa LL, Rahal P, Franco EL(*). Molecular variant analysis as a tool in natural history studies of human papillomavirus infection and cervical neoplasia. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 379-385).
  17. Franco EL. Rapporteurs’ summary of presentations. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 453-461).
  18. Franco EL. Highlights and consensus. In: Franco EL, Monsonego J (eds.) New developments in cervical cancer screening and prevention. Blackwell, Oxford, 1997 (pp. 462-464).
  19. Franco EL. Epidemiology of uterine cancers (chapter 14). In: Meisels A, Morin C (eds.) Cytopathology of the uterus, 2nd Edition. American Society of Clinical Pathologists, Chicago, 1997 (pp. 301-324).
  20. Latorre MR(§), Franco EL(*). Epidemiologia do câncer de ovário. In: Abrao F (ed.) Cancer do ovário. Editora Roca, Sao Paulo, 1997 (pp. 51-64).
  21. Allison PJ(§), Franco E, Locker D, Feine JS. The role of delays and anatomical site in determining disease stage among oral and oropharyngeal cancers. In: Varma AK (ed.) Oral Oncology, Vol V, ICOC Press, New Delhi, 1997 (pp. 112-115).
  22. Latorre MR(§), Franco EL(*). Epidemiologia. In: Lopes AL (ed.) Sarcomas de partes moles. MEDSI Editora, Sao Paulo, 1998 (pp. 3-18).
  23. Franco EL. Statistical issues in human papillomavirus testing and screening. In: Carr J (ed.) Human Papillomavirus. Clinics in Laboratory Medicine, W.B. Saunders, Philadelphia, 2000 (pp 345-367).
  24. Carvalho AL(§), Schlecht NF, Pintos J, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Factors influencing patient and professional delay in oral cancer diagnosis. In: Varma AK, Roodenburg JLN (eds.) Oral Oncology, Vol VII, ICOC Press, The Hague, 2001 (pp. 31-34).
  25. Carvalho AL(§), Pintos J, Schlecht NF, Oliveira BV, Fava AS, Curado MP, Kowalski LP, Franco EL. Incidence of second primary tumours in a cohort of head and neck cancer patients in Brazil. In: Varma AK, Roodenburg JLN (eds.) Oral Oncology, Vol VII, ICOC Press, The Hague, 2001 (pp. 72-74).
  26. Rohan TE, Franco EL. Introduction. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 1-3).
  27. Franco EL, Rohan TE. Assessing epidemiologic relations and the role of measurement errors. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 60-74).
  28. Franco EL, Ferenczy A. Cervix. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 249-286).
  29. Franco EL, Ferenczy A. Endometrium. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 287-303).
  30. Franco EL, Rohan TE. Evidence-based policy recommendations on screening and prevention. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 389-403).
  31. Rohan TE, Franco EL. Prospects. In: Franco EL, Rohan TE (eds.) Cancer Precursors: Epidemiology, Detection, and Prevention. Springer-Verlag, New York, 2002 (pp. 407-410).
  32. Rousseau MC(§), Franco EL(*). Détection des infections à HPV. In: Aubin F, Pretet JL, Mougin C (eds.) Papillomavirus humains, biologie et pathologie tumorale. Editions Médicales Internationales, Paris, 2003 (pp. 601-626).
  33. Carvalho A(§), Pintos J, Schlecht N, Oliveira B, Fava A, Curado MP, Kowalski LP, Franco EL. Age and alcohol consumption influence prognosis of head and neck cancer patients. In: Varma AK, Reade P (eds.) Oral Oncology, Vol 9, MacMillan Press, India, 2003 (pp. 101-103).
  34. Tortolero-Luna G, Franco EL. Epidemiology of cervical, vulvar, and vaginal cancer: Unresolved issues and future research. In: Gershenson DM, Gore M, Quinn MJ, Thomas G (Eds.). Gynecologic cancer: Controversies in management. Elsevier Science and Churchill Livingstone (pp. 3-30), ISBN:044307142X, 2004.
  35. Franco EL. The Role of Viruses in Oncogenesis: Human Papillomaviruses and Cervical Cancer as a Paradigm. In: Knobler S, O'Connor S, Lemon S (eds.). The Infectious Etiology of Chronic Diseases: Defining the Relationship, Enhancing the Research, and Mitigating the Effects. National Academy Press, Washington, D.C. 2004, pp. 17-28 (ISBN 0-309-08994-8).
  36. Duarte-Franco E, Franco EL(*). Cancer of the Colon and Rectum: Epidemiology and Risk factors. In: Rossi BM (ed.) Cancer of the Colon, Rectum and Anus, Lemar and Tecmedd, Sao Paulo, 2005, pp. 3-22, ISBN 858665303-9.
  37. Duarte-Franco E, Franco EL(*). Cancer of the Anus: Epidemiology and Risk Factors. In: Rossi BM (ed.) Cancer of the Colon, Rectum and Anus, Lemar and Tecmedd, Sao Paulo, 2005, pp. 665-678, ISBN 858665303-9.
  38. Franco EL, Duarte-Franco E, Ferenczy A. Perspectivas para controlar el cáncer cervicouterino en el siglo XXI. In: Alonso PA, Lazcano-Ponce E, Hernández-Avila M (eds.) Cáncer Cervicouterino: Diagnóstico, Prevención y Control. Editora Medica Panamericana, Mexico DF, 2005, pp. 251-262, ISBN 9687988509.
  39. Burchell AN(§), Franco EL(*). Epidemiology of oncogenic and nononcogenic HPV types, and the evidence for differences in their sexual transmissibility. In: Monsonego J (ed.) Emerging issues on HPV infections: From science to practice. Karger AG, Basel, 2006, pp. 20-33, ISBN 3-8055-8120-3.
  40. Duarte-Franco E, Franco EL(*). Epidemiologia do cancer mamario e ginecologico. In: Abrao F (ed.) Tratado de oncologia genital e mamaria. 2a. Edição, Editora Revinter, Sao Paulo, 2006, pp. 1-25, ISBN 85-372-0005-0.
  41. Rohan TE, Henson D, Franco EL, Albores-Saavedra J. Cancer Precursors. In: Schottenfeld D, Fraumeni J (eds.) Cancer Epidemiology and Prevention, 3rd edition, Oxford University Press, 2006; pp. 21-46, ISBN-13: 978-0-19-514961-6 and ISBN-10: 0-19-514961-0.
  42. Koushik A(§), Franco EL(*). Chapter 18: Epidemiology and the role of human papillomaviruses. In: Jordan JA, Singer A (eds.) The Cervix, 2nd Edition, Blackwell, Oxford, 2006, pp. 259-276, ISBN-13: 978-1-4051-3137-7, ISBN-10: 1-4051-3137-3.
  43. Spence A(§), Franco EL(*). Chapter 26: Screening for cervical cancer using HPV tests. In: Jordan JA, Singer A (eds.) The Cervix, 2nd Edition, Blackwell, Oxford, 2006, pp. 373-386, ISBN-13: 978-1-4051-3137-7, ISBN-10: 1-4051-3137-3.
  44. Franco EL, Mahmud S, Dean AG. Epidemiological Methods: A View from the Americas. In: Holland W, Olsen J, Florey C (eds.) The Development of Modern Epidemiology. Oxford University Press, 2007, pp. 275-287, ISBN 978-0-19-856954-1.
  45. Mayrand MH(§), Franco EL(*). Chapter 8: Prevention of uterine cancers. In: Meisels A, Morin C (eds.) Modern Uterine Cytopathology. American Society of Clinical Pathologists, ASCP Press, Chicago, 2007, pp. 136-154.
  46. Spence A(§), Franco EL(*). Chapter 9: Epidemiology of uterine cancers. In: Meisels A, Morin C (eds.) Modern Uterine Cytopathology. American Society of Clinical Pathologists, ASCP Press, Chicago, 2007, pp. 155-168.
  47. Franco EL. Human Papillomavirus and Cervical Cancer: Integrating the New Prevention Strategies. In: AACR Education Book 2008, American Association for Cancer Research, San Diego, 2008, pp. 367-373.
  48. Trottier H(§), Franco EL(*). A prevenção do câncer do colo do útero na era da vacinação contra o HPV (“Prevention of cervical cancer in the era of HPV vaccination”. In: Coelho F et al. (eds.) Câncer do Colo do Útero. Tecmedd Editora, Sao Paulo, 2008, pp. 162-168, ISBN 978-85-99276-25-9.
  49. Trottier H(§), Franco EL(*). Impact potentiel de la vaccination HPV dans les programmes de dépistage du cancer du col utérin. In: Monsonego J (ed.) Traité des infections et pathologies génitales à papillomavirus. Editions Springer, Paris, 2008, ISBN 978-2-287-72064-2.
  50. Tota J (§), Franco EL(*). Chapter 12: HPV Infection and Cervical Carcinogenesis: Epidemiology and Prevention. In: Ayhan A, Gultekin M, Dursum P (eds.) Textbook of Gynaecological Oncology, European Society of Gynecologic Oncology, Gunes Publishing, Ankara, 2009, pp 49-52, ISBN 978-975-277-267-0.
  51. Trottier H(§), Franco EL(*).Chapter 23. Infectious diseases and cancer: HPV. In: Krämer A, Kretzschmar M, Krickeberg K (eds.) Modern infectious disease epidemiology: Concepts, methods, mathematical models, and public health. Springer 2010, ISBN 978-0-387-93834-9.
  52. Burchell AN(§), Franco EL(*). Chapter 6: The impact of immunization on cancer control: The example of HPV vaccination. In: Elwood JM, Sutcliffe SB (eds.) Cancer Control. Oxford University Press, Oxford, UK, 2010, pp 101-128, ISBN 978-0-19-955017-3.
  53. Coutlée F, Franco EL(*). Chapter 10: Infectious Agents. In: Rothman N, Hainaut P, Schulte P, Smith M, Boffetta P, Perera F (eds.) Molecular Epidemiology: Principles and Practices. International Agency for Research on Cancer, Scientific Publication No. 163, World Health Organization, Geneva, 2011, pp. 175-188, ISBN 978-92-832-2163-0.
  54. De Pokomandy A(§), Franco EL(*). Chapter 15: HPV Infection and Cervical Carcinogenesis: Epidemiology and Prevention. In: Ayhan A, Reed N, Gultekin M, Dursum P (eds.) Textbook of Gynaecological Oncology, 2nd Edition, European Society of Gynecologic Oncology, Gunes Publishing, Ankara, 2012, pp. 73-77, ISBN 978-975-277-387-5.
  55. Chevarie-Davis M(§), Franco EL(*). Chapter 78: Vaccination and screening in cervical cancer control and prevention. In: Goldman MB, Troisi R, Rexrode KM (Eds). Women and health, 2nd edition, Elsevier, Amsterdam, 2013, pp. 1175-1189, ISBN 978-0-12-384978-6.
  56. Louvanto K(§*), Isidean SD, Franco EL. Chapter 1: Epidemiology. In: Grigsby P (Ed.). Cervical Cancer. Future Medicine E-Book, Future Science Group. (in press).
  57. Isidean SD(§*), Louvanto K, Franco EL. Chapter 3: Screening. In: Grigsby P (Ed.). Cervical Cancer. Future Medicine E-Book, Future Science Group. (in press).
Tags: 
Dentistry Research
Back to top